| Category | Name | IntersectionWithQuery | PValue | GenesInTerm | GenesInQuery | GenesInTermInQuery | ID |
|---|---|---|---|---|---|---|---|
| GeneOntologyMolecularFunction | catalytic activity, acting on DNA | ERVK-6 EME1 ERCC6 ATAD5 POLG CHD7 ERVK-7 RFC1 DHX30 HELB ERVK-8 REV1 | 4.16e-08 | 262 | 116 | 12 | GO:0140097 |
| GeneOntologyMolecularFunction | catalytic activity, acting on a nucleic acid | DTD1 ERVK-6 EME1 ERCC6 ATAD5 POLG CHD7 ERVK-7 RFC1 NSUN2 DHX30 HELB DHX15 ERVK-8 SMG6 REV1 | 1.01e-06 | 645 | 116 | 16 | GO:0140640 |
| GeneOntologyMolecularFunction | DNA polymerase activity | 2.61e-06 | 38 | 116 | 5 | GO:0034061 | |
| GeneOntologyMolecularFunction | RNA-DNA hybrid ribonuclease activity | 3.05e-05 | 11 | 116 | 3 | GO:0004523 | |
| GeneOntologyMolecularFunction | DNA clamp unloader activity | 3.35e-05 | 2 | 116 | 2 | GO:0061860 | |
| GeneOntologyMolecularFunction | ATP hydrolysis activity | KIF13B ERCC6 ATAD5 CHD7 RFC1 DHX30 HELB DHX15 MDN1 DNAH6 ATP2B4 | 5.28e-05 | 441 | 116 | 11 | GO:0016887 |
| GeneOntologyMolecularFunction | aspartic-type endopeptidase activity | 6.16e-05 | 37 | 116 | 4 | GO:0004190 | |
| GeneOntologyMolecularFunction | RNA-directed DNA polymerase activity | 6.64e-05 | 14 | 116 | 3 | GO:0003964 | |
| GeneOntologyMolecularFunction | aspartic-type peptidase activity | 6.85e-05 | 38 | 116 | 4 | GO:0070001 | |
| GeneOntologyMolecularFunction | ATP-dependent activity, acting on DNA | 9.85e-05 | 127 | 116 | 6 | GO:0008094 | |
| GeneOntologyMolecularFunction | RNA stem-loop binding | 2.35e-04 | 21 | 116 | 3 | GO:0035613 | |
| GeneOntologyMolecularFunction | ATP-dependent activity | KIF13B ERCC6 ATAD5 MYO1B CHD7 RFC1 DHX30 HELB DHX15 MDN1 DNAH6 ATP2B4 | 2.40e-04 | 614 | 116 | 12 | GO:0140657 |
| GeneOntologyMolecularFunction | ribonucleoside triphosphate phosphatase activity | RAB23 KIF13B ERCC6 ATAD5 CHD7 RFC1 DHX30 HELB DHX15 MDN1 RRAGD DNAH6 ATP2B4 | 5.68e-04 | 775 | 116 | 13 | GO:0017111 |
| GeneOntologyMolecularFunction | histone binding | 9.14e-04 | 265 | 116 | 7 | GO:0042393 | |
| GeneOntologyMolecularFunction | Wnt-protein binding | 1.00e-03 | 34 | 116 | 3 | GO:0017147 | |
| GeneOntologyMolecularFunction | RNA endonuclease activity | 1.16e-03 | 79 | 116 | 4 | GO:0004521 | |
| GeneOntologyMolecularFunction | pyrophosphatase activity | RAB23 KIF13B ERCC6 ATAD5 CHD7 RFC1 DHX30 HELB DHX15 MDN1 RRAGD DNAH6 ATP2B4 | 1.18e-03 | 839 | 116 | 13 | GO:0016462 |
| GeneOntologyMolecularFunction | hydrolase activity, acting on acid anhydrides | RAB23 KIF13B ERCC6 ATAD5 CHD7 RFC1 DHX30 HELB DHX15 MDN1 RRAGD DNAH6 ATP2B4 | 1.19e-03 | 840 | 116 | 13 | GO:0016817 |
| GeneOntologyMolecularFunction | hydrolase activity, acting on acid anhydrides, in phosphorus-containing anhydrides | RAB23 KIF13B ERCC6 ATAD5 CHD7 RFC1 DHX30 HELB DHX15 MDN1 RRAGD DNAH6 ATP2B4 | 1.19e-03 | 840 | 116 | 13 | GO:0016818 |
| GeneOntologyMolecularFunction | endonuclease activity | 1.19e-03 | 136 | 116 | 5 | GO:0004519 | |
| GeneOntologyMolecularFunction | RNA endonuclease activity, producing 5'-phosphomonoesters | 1.29e-03 | 37 | 116 | 3 | GO:0016891 | |
| GeneOntologyMolecularFunction | modification-dependent protein binding | 1.30e-03 | 206 | 116 | 6 | GO:0140030 | |
| GeneOntologyMolecularFunction | nucleotidyltransferase activity | 1.95e-03 | 152 | 116 | 5 | GO:0016779 | |
| GeneOntologyMolecularFunction | histone ubiquitin ligase activity | 2.13e-03 | 12 | 116 | 2 | GO:0140852 | |
| GeneOntologyMolecularFunction | helicase activity | 2.31e-03 | 158 | 116 | 5 | GO:0004386 | |
| GeneOntologyMolecularFunction | nuclease activity | 2.32e-03 | 231 | 116 | 6 | GO:0004518 | |
| GeneOntologyMolecularFunction | endonuclease activity, active with either ribo- or deoxyribonucleic acids and producing 5'-phosphomonoesters | 2.42e-03 | 46 | 116 | 3 | GO:0016893 | |
| GeneOntologyMolecularFunction | catalytic activity, acting on RNA | 3.02e-03 | 417 | 116 | 8 | GO:0140098 | |
| GeneOntologyBiologicalProcess | DNA metabolic process | DTD1 ERVK-6 PDS5B EME1 SP100 ERCC6 RNF168 ATAD5 POLG TOPBP1 TFIP11 ERVK-7 JADE1 RFC1 TRIP12 HORMAD1 HELB DBF4 PRIM2 CHEK2 ERVK-8 UHRF1 FOXP1 SMG6 REV1 | 6.78e-10 | 1081 | 113 | 25 | GO:0006259 |
| GeneOntologyBiologicalProcess | DNA replication | DTD1 ERVK-6 EME1 ATAD5 POLG TOPBP1 ERVK-7 JADE1 RFC1 HELB DBF4 PRIM2 ERVK-8 REV1 | 1.76e-09 | 312 | 113 | 14 | GO:0006260 |
| GeneOntologyBiologicalProcess | DNA-templated DNA replication | ERVK-6 EME1 ATAD5 POLG TOPBP1 ERVK-7 RFC1 HELB DBF4 PRIM2 ERVK-8 | 3.93e-09 | 178 | 113 | 11 | GO:0006261 |
| GeneOntologyBiologicalProcess | DNA repair | ERVK-6 PDS5B EME1 ERCC6 RNF168 POLG TOPBP1 TFIP11 ERVK-7 RFC1 TRIP12 HELB CHEK2 ERVK-8 UHRF1 REV1 | 4.91e-07 | 648 | 113 | 16 | GO:0006281 |
| GeneOntologyBiologicalProcess | DNA damage response | ERVK-6 PDS5B EME1 SP100 ERCC6 RNF168 ATAD5 POLG TOPBP1 TFIP11 ERVK-7 RFC1 TRIP12 HELB CHEK2 ERVK-8 UHRF1 FOXP1 REV1 | 1.08e-06 | 959 | 113 | 19 | GO:0006974 |
| GeneOntologyBiologicalProcess | cell cycle phase transition | EME1 ARPP19 ERCC6 ATAD5 TOPBP1 JADE1 PHF8 NSUN2 HORMAD1 LARP7 DBF4 CHEK2 CDC27 ATP2B4 NPAT | 1.71e-06 | 627 | 113 | 15 | GO:0044770 |
| GeneOntologyBiologicalProcess | chromosome organization | DTD1 PDS5B SP100 CENPC TOPBP1 TFIP11 RFC1 HORMAD1 DHX30 HELB RESF1 CHEK2 UHRF1 CDC27 SMG6 | 5.11e-06 | 686 | 113 | 15 | GO:0051276 |
| GeneOntologyBiologicalProcess | DNA recombination | ERVK-6 EME1 ERCC6 RNF168 ATAD5 TOPBP1 ERVK-7 HELB ERVK-8 UHRF1 FOXP1 | 5.75e-06 | 368 | 113 | 11 | GO:0006310 |
| GeneOntologyBiologicalProcess | double-strand break repair via classical nonhomologous end joining | 1.31e-05 | 9 | 113 | 3 | GO:0097680 | |
| GeneOntologyBiologicalProcess | DNA biosynthetic process | 2.71e-05 | 218 | 113 | 8 | GO:0071897 | |
| GeneOntologyBiologicalProcess | DNA clamp unloading | 2.98e-05 | 2 | 113 | 2 | GO:0090618 | |
| GeneOntologyBiologicalProcess | cell cycle process | PDS5B EME1 ARPP19 ERCC6 CENPC ATAD5 TOPBP1 JADE1 PHF8 NSUN2 HORMAD1 LARP7 DBF4 CHEK2 RBM14 UHRF1 LRP5 CDC27 ATP2B4 PHIP NPAT | 3.26e-05 | 1441 | 113 | 21 | GO:0022402 |
| GeneOntologyBiologicalProcess | DNA integration | 4.40e-05 | 13 | 113 | 3 | GO:0015074 | |
| GeneOntologyBiologicalProcess | mRNA export from nucleus | 5.38e-05 | 74 | 113 | 5 | GO:0006406 | |
| GeneOntologyBiologicalProcess | regulation of cell cycle process | EME1 ERCC6 ATAD5 TOPBP1 JADE1 NSUN2 HORMAD1 LARP7 DBF4 CHEK2 RBM14 LRP5 CDC27 ATP2B4 PHIP | 5.82e-05 | 845 | 113 | 15 | GO:0010564 |
| GeneOntologyBiologicalProcess | nuclear export | 7.23e-05 | 185 | 113 | 7 | GO:0051168 | |
| GeneOntologyBiologicalProcess | epigenetic regulation of gene expression | 8.55e-05 | 330 | 113 | 9 | GO:0040029 | |
| GeneOntologyBiologicalProcess | RNA-templated DNA biosynthetic process | 9.33e-05 | 83 | 113 | 5 | GO:0006278 | |
| GeneOntologyBiologicalProcess | protein-DNA complex organization | BDP1 ERCC6 RNF168 CENPC TOPBP1 ZDBF2 CHD7 JADE1 PHF8 TRIP12 TASOR2 RESF1 UBN1 RBM14 UHRF1 KMT2A | 1.09e-04 | 999 | 113 | 16 | GO:0071824 |
| GeneOntologyBiologicalProcess | regulation of cell cycle phase transition | EME1 ERCC6 ATAD5 TOPBP1 JADE1 NSUN2 HORMAD1 LARP7 DBF4 CHEK2 ATP2B4 | 1.26e-04 | 516 | 113 | 11 | GO:1901987 |
| GeneOntologyBiologicalProcess | DNA synthesis involved in DNA repair | 1.38e-04 | 48 | 113 | 4 | GO:0000731 | |
| GeneOntologyBiologicalProcess | regulation of cell cycle | EME1 ERCC6 ATAD5 TOPBP1 JADE1 NSUN2 HORMAD1 LARP7 TTBK1 PRCC DBF4 CHEK2 RBM14 LRP5 WDR12 CDC27 ATP2B4 PHIP | 1.59e-04 | 1256 | 113 | 18 | GO:0051726 |
| GeneOntologyBiologicalProcess | RNA export from nucleus | 1.86e-04 | 96 | 113 | 5 | GO:0006405 | |
| GeneOntologyBiologicalProcess | chromatin remodeling | ERCC6 RNF168 ZDBF2 CHD7 JADE1 PHF8 TRIP12 TASOR2 RESF1 UBN1 RBM14 UHRF1 KMT2A | 2.11e-04 | 741 | 113 | 13 | GO:0006338 |
| GeneOntologyBiologicalProcess | nuclear transport | 2.37e-04 | 378 | 113 | 9 | GO:0051169 | |
| GeneOntologyBiologicalProcess | nucleocytoplasmic transport | 2.37e-04 | 378 | 113 | 9 | GO:0006913 | |
| GeneOntologyBiologicalProcess | viral process | ERVK-6 SP100 RRP1B ERVK-7 IFIT1 LARP7 RESF1 ERVK-8 ERVK-19 PPIE | 2.37e-04 | 464 | 113 | 10 | GO:0016032 |
| GeneOntologyBiologicalProcess | mitotic cell cycle process | EME1 ARPP19 CENPC ATAD5 TOPBP1 JADE1 PHF8 LARP7 DBF4 CHEK2 UHRF1 LRP5 CDC27 PHIP | 2.39e-04 | 854 | 113 | 14 | GO:1903047 |
| GeneOntologyBiologicalProcess | Norrin signaling pathway | 2.94e-04 | 5 | 113 | 2 | GO:0110135 | |
| GeneOntologyBiologicalProcess | extracellular matrix-cell signaling | 2.94e-04 | 5 | 113 | 2 | GO:0035426 | |
| GeneOntologyBiologicalProcess | regulation of heterochromatin formation | 2.98e-04 | 24 | 113 | 3 | GO:0031445 | |
| GeneOntologyBiologicalProcess | chromatin organization | ERCC6 RNF168 TOPBP1 ZDBF2 CHD7 JADE1 PHF8 TRIP12 TASOR2 RESF1 UBN1 RBM14 UHRF1 KMT2A | 3.88e-04 | 896 | 113 | 14 | GO:0006325 |
| GeneOntologyBiologicalProcess | double-strand break repair | 4.17e-04 | 324 | 113 | 8 | GO:0006302 | |
| GeneOntologyBiologicalProcess | retinal blood vessel morphogenesis | 4.40e-04 | 6 | 113 | 2 | GO:0061304 | |
| GeneOntologyBiologicalProcess | negative regulation of heterochromatin formation | 4.40e-04 | 6 | 113 | 2 | GO:0031452 | |
| GeneOntologyBiologicalProcess | camera-type eye development | 5.65e-04 | 426 | 113 | 9 | GO:0043010 | |
| GeneOntologyBiologicalProcess | DNA replication, synthesis of primer | 6.14e-04 | 7 | 113 | 2 | GO:0006269 | |
| GeneOntologyBiologicalProcess | negative regulation of chromatin organization | 6.14e-04 | 7 | 113 | 2 | GO:1905268 | |
| GeneOntologyBiologicalProcess | ribosomal large subunit biogenesis | 6.95e-04 | 73 | 113 | 4 | GO:0042273 | |
| GeneOntologyBiologicalProcess | embryo development | RAB23 CACNA1C FN1 CEP290 CHD7 THOC2 NSUN2 TRIP12 HORMAD1 RBM14 CTHRC1 KMT2A LRP5 N4BP2L2 FOXP1 ALPI INVS NPAT | 8.00e-04 | 1437 | 113 | 18 | GO:0009790 |
| GeneOntologyBiologicalProcess | rRNA metabolic process | 8.05e-04 | 275 | 113 | 7 | GO:0016072 | |
| GeneOntologyBiologicalProcess | negative regulation of double-strand break repair via nonhomologous end joining | 8.15e-04 | 8 | 113 | 2 | GO:2001033 | |
| GeneOntologyBiologicalProcess | regulation of endothelial tube morphogenesis | 8.15e-04 | 8 | 113 | 2 | GO:1901509 | |
| GeneOntologyBiologicalProcess | signal transduction in response to DNA damage | 8.24e-04 | 200 | 113 | 6 | GO:0042770 | |
| GeneOntologyBiologicalProcess | double-strand break repair via nonhomologous end joining | 8.50e-04 | 77 | 113 | 4 | GO:0006303 | |
| GeneOntologyBiologicalProcess | negative regulation of cell cycle process | 8.61e-04 | 362 | 113 | 8 | GO:0010948 | |
| GeneOntologyBiologicalProcess | negative regulation of gene expression, epigenetic | 8.91e-04 | 203 | 113 | 6 | GO:0045814 | |
| GeneOntologyCellularComponent | nuclear body | SP100 ERCC6 CENPC MAMLD1 TOPBP1 TFIP11 JADE1 THOC2 TRIP12 HELB DHX15 UBN1 PRCC DBF4 CHEK2 RBM14 PPIE NPAT | 1.86e-06 | 903 | 114 | 18 | GO:0016604 |
| GeneOntologyCellularComponent | replication fork | 6.38e-05 | 77 | 114 | 5 | GO:0005657 | |
| GeneOntologyCellularComponent | U2-type post-mRNA release spliceosomal complex | 8.81e-05 | 3 | 114 | 2 | GO:0071008 | |
| GeneOntologyCellularComponent | Elg1 RFC-like complex | 8.81e-05 | 3 | 114 | 2 | GO:0031391 | |
| GeneOntologyCellularComponent | nuclear protein-containing complex | SP100 ERCC6 TOPBP1 TFIP11 POLR1G THOC2 LARP7 HELB DHX15 ZC3H11A DBF4 PRIM2 KMT2A WDR12 PPIE MPHOSPH10 CDC27 SMG6 | 4.62e-04 | 1377 | 114 | 18 | GO:0140513 |
| Domain | BRCT | 4.92e-06 | 19 | 115 | 4 | PF00533 | |
| Domain | BRCT | 9.16e-06 | 22 | 115 | 4 | SM00292 | |
| Domain | - | 1.10e-05 | 23 | 115 | 4 | 3.40.50.10190 | |
| Domain | BRCT | 1.84e-05 | 26 | 115 | 4 | PS50172 | |
| Domain | BRCT_dom | 2.49e-05 | 28 | 115 | 4 | IPR001357 | |
| Domain | ZnF_DBF | 1.12e-04 | 3 | 115 | 2 | SM00586 | |
| Domain | ZF_DBF4 | 1.12e-04 | 3 | 115 | 2 | PS51265 | |
| Domain | Znf_DBF | 1.12e-04 | 3 | 115 | 2 | IPR006572 | |
| Domain | zf-DBF | 1.12e-04 | 3 | 115 | 2 | PF07535 | |
| Domain | P-loop_NTPase | RAB23 KIF13B ERCC6 ATAD5 MAGI3 MYO1B CHD7 RFC1 DHX30 HELB DHX15 MDN1 RRAGD N4BP2L2 DNAH6 | 2.20e-04 | 848 | 115 | 15 | IPR027417 |
| Domain | G_PATCH | 3.68e-04 | 23 | 115 | 3 | PS50174 | |
| Domain | G_patch | 3.68e-04 | 23 | 115 | 3 | SM00443 | |
| Domain | G_patch_dom | 3.68e-04 | 23 | 115 | 3 | IPR000467 | |
| Domain | G-patch | 3.68e-04 | 23 | 115 | 3 | PF01585 | |
| Domain | DDE_Tnp_1_7 | 3.71e-04 | 5 | 115 | 2 | PF13843 | |
| Domain | PGBD | 3.71e-04 | 5 | 115 | 2 | IPR029526 | |
| Domain | PHD | 1.18e-03 | 75 | 115 | 4 | PF00628 | |
| Domain | DNA/RNA_helicase_DEAH_CS | 1.29e-03 | 35 | 115 | 3 | IPR002464 | |
| Domain | Znf_PHD-finger | 1.44e-03 | 79 | 115 | 4 | IPR019787 | |
| Domain | DEAH_ATP_HELICASE | 1.64e-03 | 38 | 115 | 3 | PS00690 | |
| Domain | AAA | 1.98e-03 | 144 | 115 | 5 | SM00382 | |
| Domain | AAA+_ATPase | 1.98e-03 | 144 | 115 | 5 | IPR003593 | |
| Domain | - | RAB23 ERCC6 ATAD5 CHD7 RFC1 DHX30 HELB DHX15 MDN1 RRAGD N4BP2L2 DNAH6 | 2.16e-03 | 746 | 115 | 12 | 3.40.50.300 |
| Domain | PHD | 2.23e-03 | 89 | 115 | 4 | SM00249 | |
| Domain | Znf_PHD | 2.41e-03 | 91 | 115 | 4 | IPR001965 | |
| Domain | ZF_PHD_2 | 2.82e-03 | 95 | 115 | 4 | PS50016 | |
| Domain | ZF_PHD_1 | 2.93e-03 | 96 | 115 | 4 | PS01359 | |
| Domain | ZnF_C3H1 | 3.21e-03 | 48 | 115 | 3 | SM00356 | |
| Domain | ATPase_dyneun-rel_AAA | 3.26e-03 | 14 | 115 | 2 | IPR011704 | |
| Domain | AAA_5 | 3.26e-03 | 14 | 115 | 2 | PF07728 | |
| Domain | AT_hook | 4.26e-03 | 16 | 115 | 2 | PF02178 | |
| Domain | Helicase_C | 4.33e-03 | 107 | 115 | 4 | PF00271 | |
| Domain | HELICc | 4.33e-03 | 107 | 115 | 4 | SM00490 | |
| Domain | Helicase_C | 4.47e-03 | 108 | 115 | 4 | IPR001650 | |
| Domain | HELICASE_CTER | 4.62e-03 | 109 | 115 | 4 | PS51194 | |
| Domain | HELICASE_ATP_BIND_1 | 4.62e-03 | 109 | 115 | 4 | PS51192 | |
| Domain | DEXDc | 4.62e-03 | 109 | 115 | 4 | SM00487 | |
| Domain | Helicase_ATP-bd | 4.77e-03 | 110 | 115 | 4 | IPR014001 | |
| Domain | DUF1605 | 4.81e-03 | 17 | 115 | 2 | IPR011709 | |
| Domain | OB_NTP_bind | 4.81e-03 | 17 | 115 | 2 | PF07717 | |
| Domain | HA2 | 5.39e-03 | 18 | 115 | 2 | SM00847 | |
| Domain | HA2 | 5.39e-03 | 18 | 115 | 2 | PF04408 | |
| Domain | Helicase-assoc_dom | 5.39e-03 | 18 | 115 | 2 | IPR007502 | |
| Domain | Znf_CCCH | 5.49e-03 | 58 | 115 | 3 | IPR000571 | |
| Domain | ZF_C3H1 | 5.49e-03 | 58 | 115 | 3 | PS50103 | |
| Domain | PUA-like_domain | 6.00e-03 | 19 | 115 | 2 | IPR015947 | |
| Pubmed | The in vivo Interaction Landscape of Histones H3.1 and H3.3. | PDS5B ERCC6 RNF168 CENPC RRP1B ATAD5 TOPBP1 CHD7 RFC1 PHF8 TRIP12 UBN1 FAM169A CTHRC1 UHRF1 KMT2A WDR12 CDC27 PHIP RBM34 ZNF292 NPAT | 2.30e-16 | 608 | 121 | 22 | 36089195 |
| Pubmed | PDS5B FN1 RRP1B MYO1B CHD7 RFC1 THOC2 NSUN2 TRIP12 LARP7 TASOR2 DHX30 DHX15 ZC3H11A MDN1 KMT2A WDR12 MPHOSPH10 PHIP RBM34 | 1.34e-13 | 653 | 121 | 20 | 22586326 | |
| Pubmed | The Nse5/6-like SIMC1-SLF2 complex localizes SMC5/6 to viral replication centers. | PDS5B CENPC RRP1B ATAD5 TOPBP1 TFIP11 ZDBF2 CHD7 RFC1 THOC2 SSX1 TRIP12 TASOR2 DHX15 ZC3H11A UBN1 PRCC RBM14 KMT2A MPHOSPH10 PHIP NPAT | 2.04e-12 | 954 | 121 | 22 | 36373674 |
| Pubmed | The E3 ubiquitin ligase HECTD1 contributes to cell proliferation through an effect on mitosis. | PDS5B ERCC6 RRP1B ATAD5 TOPBP1 RFC1 PHF8 POLR1G THOC2 NSUN2 TRIP12 LARP7 DHX30 ZC3H11A MDN1 RBM14 UHRF1 WDR12 MPHOSPH10 RBM34 | 2.10e-12 | 759 | 121 | 20 | 35915203 |
| Pubmed | ERCC6 RRP1B MYO1B TFIP11 RFC1 POLR1G THOC2 TRIP12 LARP7 DHX30 DHX15 ZC3H11A MDN1 PITX3 RBM14 KMT2A FOXP1 WDR12 MPHOSPH10 RBM34 | 1.51e-11 | 847 | 121 | 20 | 35850772 | |
| Pubmed | Proteomic profiling of VCP substrates links VCP to K6-linked ubiquitylation and c-Myc function. | PDS5B ERCC6 FN1 CENPC MYO1B TFIP11 CHD7 RFC1 PHF8 POLR1G NSUN2 TRIP12 DHX30 DHX15 ZGPAT ZC3H11A MDN1 UBN1 PRIM2 RBM14 CDC27 PHIP RBM34 | 2.67e-10 | 1353 | 121 | 23 | 29467282 |
| Pubmed | H4K20me0 recognition by BRCA1-BARD1 directs homologous recombination to sister chromatids. | EME1 RNF168 RRP1B ATAD5 CEP290 TOPBP1 ELOVL1 TFIP11 CHD7 RFC1 PHF8 POLR1G THOC2 TRIP12 DHX15 ZC3H11A MDN1 UBN1 RBM14 UHRF1 KMT2A CDC27 | 6.88e-10 | 1294 | 121 | 22 | 30804502 |
| Pubmed | Large-scale characterization of HeLa cell nuclear phosphoproteins. | PDS5B EME1 TFIP11 CHD7 RFC1 PHF8 POLR1G THOC2 NSUN2 TRIP12 ZC3H11A MDN1 UBN1 DBF4 RBM14 KMT2A ALPI | 1.73e-09 | 774 | 121 | 17 | 15302935 |
| Pubmed | ASNSD1 DTD1 FN1 RRP1B MYO1B TFIP11 CHD7 RFC1 THOC2 NSUN2 TRIP12 LARP7 DHX15 RRAGD CSNK1G1 RBM14 UHRF1 KMT2A WDR12 FTL ATP2B4 RBM34 | 2.00e-09 | 1371 | 121 | 22 | 36244648 | |
| Pubmed | PDS5B RNF168 CENPC ATAD5 RFC1 PHF8 POLR1G THOC2 NSUN2 LARP7 DHX15 ZC3H11A MDN1 UBN1 PRIM2 RBM14 UHRF1 KMT2A BZW1 | 2.40e-09 | 1014 | 121 | 19 | 32416067 | |
| Pubmed | BAP1 regulation of the key adaptor protein NCoR1 is critical for γ-globin gene repression. | PDS5B RRP1B TFIP11 CHD7 RFC1 POLR1G THOC2 NSUN2 TRIP12 LARP7 DHX30 DHX15 MDN1 CCDC71 KMT2A WDR12 MPHOSPH10 BZW1 CDC27 PHIP RBM34 | 5.53e-09 | 1318 | 121 | 21 | 30463901 |
| Pubmed | Interactome Rewiring Following Pharmacological Targeting of BET Bromodomains. | PDS5B CENPC RRP1B ATAD5 RFC1 PHF8 THOC2 TRIP12 MDN1 UHRF1 KMT2A WDR12 CDC27 PHIP | 5.63e-09 | 533 | 121 | 14 | 30554943 |
| Pubmed | 6.25e-09 | 222 | 121 | 10 | 37071664 | ||
| Pubmed | EME1 CENPC ATAD5 CEP290 TOPBP1 RFC1 THOC2 TRIP12 LARP7 UBN1 RBM14 FAM169A UHRF1 KMT2A PHIP | 7.93e-09 | 645 | 121 | 15 | 25281560 | |
| Pubmed | PDS5B CEP290 CHD7 RFC1 TRIP12 TASOR2 HELB ZGPAT ZC3H11A UHRF1 KMT2A PCMTD2 PHIP | 1.08e-08 | 469 | 121 | 13 | 27634302 | |
| Pubmed | ERCC6 MLEC RRP1B ATAD5 TOPBP1 ELOVL1 TFIP11 CHD7 POLR1G LARP7 DHX30 ZGPAT ZC3H11A MDN1 MTFR1 KMT2A WDR12 PPIE MPHOSPH10 CDC27 SMG6 | 4.93e-08 | 1497 | 121 | 21 | 31527615 | |
| Pubmed | MYC multimers shield stalled replication forks from RNA polymerase. | CENPC RRP1B MYO1B TFIP11 RFC1 POLR1G THOC2 NSUN2 TRIP12 DHX30 DHX15 ZC3H11A MDN1 RBM14 UHRF1 WDR12 MPHOSPH10 | 6.27e-08 | 989 | 121 | 17 | 36424410 |
| Pubmed | PDS5B KIF13B CACNA1C EME1 SP100 CENPC KRT34 MAGI3 MYO1B TRIP12 LARP7 TASOR2 ADAMTS12 MDN1 FAM169A KMT2A MPHOSPH10 CDC27 DNAH6 ZNF292 | 1.29e-07 | 1442 | 121 | 20 | 35575683 | |
| Pubmed | FBXO22 promotes leukemogenesis by targeting BACH1 in MLL-rearranged acute myeloid leukemia. | BDP1 PDS5B CACNA1C ERCC6 FN1 TFIP11 TRIP12 MDN1 KMT2A WDR12 RBM34 ZNF292 | 1.82e-07 | 497 | 121 | 12 | 36774506 |
| Pubmed | SP100 RRP1B TRIP12 LARP7 DHX30 RBM14 WDR12 MPHOSPH10 PHIP RBM34 | 2.72e-07 | 332 | 121 | 10 | 25693804 | |
| Pubmed | Targeting USP10 induces degradation of oncogenic ANLN in esophageal squamous cell carcinoma. | DTD1 SP100 ERCC6 RRP1B MYO1B RFC1 THOC2 NSUN2 TRIP12 TASOR2 DHX30 DHX15 ZC3H11A RBM14 WDR12 PPIE MPHOSPH10 RBM34 | 3.71e-07 | 1257 | 121 | 18 | 36526897 |
| Pubmed | Quantitation of HERV-K env gene expression and splicing in human breast cancer. | 4.09e-07 | 5 | 121 | 3 | 12629516 | |
| Pubmed | The functional interactome of PYHIN immune regulators reveals IFIX is a sensor of viral DNA. | RRP1B NSUN2 TRIP12 LARP7 DHX30 UBN1 WDR12 MPHOSPH10 PHIP RBM34 | 4.30e-07 | 349 | 121 | 10 | 25665578 |
| Pubmed | 7.76e-07 | 210 | 121 | 8 | 16565220 | ||
| Pubmed | KIF13B STARD8 FN1 POLG TFIP11 CHD7 JADE1 THOC2 TRIP12 ZC3H11A RESF1 RRAGD N4BP2L2 MPHOSPH10 CDC27 NPAT | 1.19e-06 | 1084 | 121 | 16 | 11544199 | |
| Pubmed | WDR76 Co-Localizes with Heterochromatin Related Proteins and Rapidly Responds to DNA Damage. | 1.29e-06 | 394 | 121 | 10 | 27248496 | |
| Pubmed | Genetic Screens Reveal FEN1 and APEX2 as BRCA2 Synthetic Lethal Targets. | 1.37e-06 | 157 | 121 | 7 | 30686591 | |
| Pubmed | CHD3 and CHD4 form distinct NuRD complexes with different yet overlapping functionality. | RRP1B ATAD5 MYO1B TFIP11 RFC1 LARP7 DHX30 DHX15 MDN1 RBM14 KMT2A RBM34 | 1.44e-06 | 605 | 121 | 12 | 28977666 |
| Pubmed | RRP1B COL28A1 RFC1 PHF8 NSUN2 LARP7 DHX30 DHX15 ZC3H11A RBM14 FAM169A UHRF1 PPIE CDC27 RBM34 | 1.51e-06 | 971 | 121 | 15 | 33306668 | |
| Pubmed | ERCC6 RRP1B TOPBP1 RFC1 POLR1G THOC2 TRIP12 ZC3H11A RBM14 UHRF1 BZW1 | 1.59e-06 | 503 | 121 | 11 | 16964243 | |
| Pubmed | 1.74e-06 | 234 | 121 | 8 | 36243803 | ||
| Pubmed | Gain of Additional BIRC3 Protein Functions through 3'-UTR-Mediated Protein Complex Formation. | PDS5B MLEC RRP1B MYO1B RFC1 THOC2 NSUN2 LARP7 DHX30 DHX15 ZC3H11A MDN1 RBM14 UHRF1 WDR12 BZW1 PHIP RBM34 | 2.22e-06 | 1425 | 121 | 18 | 30948266 |
| Pubmed | ASNSD1 RRP1B ATAD5 MYO1B TFIP11 CHD7 RFC1 PHF8 NSUN2 DHX30 RESF1 UBN1 PRCC KMT2A FOXP1 FTL RBM34 NPAT | 2.31e-06 | 1429 | 121 | 18 | 35140242 | |
| Pubmed | 2.33e-06 | 421 | 121 | 10 | 34650049 | ||
| Pubmed | TWIST1 and chromatin regulatory proteins interact to guide neural crest cell differentiation. | 2.37e-06 | 109 | 121 | 6 | 33554859 | |
| Pubmed | Transcription factor Foxp3 and its protein partners form a complex regulatory network. | 6.28e-06 | 370 | 121 | 9 | 22922362 | |
| Pubmed | 6.64e-06 | 11 | 121 | 3 | 21425081 | ||
| Pubmed | RRP1B TFIP11 RFC1 THOC2 NSUN2 LARP7 DHX30 DHX15 ZC3H11A WDR12 MPHOSPH10 RBM34 | 7.68e-06 | 713 | 121 | 12 | 29802200 | |
| Pubmed | 8.83e-06 | 12 | 121 | 3 | 14557543 | ||
| Pubmed | MLEC RRP1B MYO1B RFC1 THOC2 NSUN2 IFIT1 LARP7 DHX15 MDN1 UBN1 RBM14 KMT2A PCMTD2 BZW1 RBM34 ALPI | 1.06e-05 | 1440 | 121 | 17 | 30833792 | |
| Pubmed | ASNSD1 RRP1B RFC1 PHF8 NSUN2 LARP7 DHX30 DHX15 RBM14 MPHOSPH10 RBM34 | 1.07e-05 | 615 | 121 | 11 | 31048545 | |
| Pubmed | 1.20e-05 | 2 | 121 | 2 | 15024691 | ||
| Pubmed | 1.20e-05 | 2 | 121 | 2 | 33606679 | ||
| Pubmed | 1.20e-05 | 2 | 121 | 2 | 23077402 | ||
| Pubmed | 1.20e-05 | 2 | 121 | 2 | 32455610 | ||
| Pubmed | 1.20e-05 | 2 | 121 | 2 | 35051531 | ||
| Pubmed | Ocular Features and Mutation Spectrum of Patients With Familial Exudative Vitreoretinopathy. | 1.20e-05 | 2 | 121 | 2 | 34860240 | |
| Pubmed | Fibronectin and Periostin as Prognostic Markers in Ovarian Cancer. | 1.20e-05 | 2 | 121 | 2 | 31936272 | |
| Pubmed | 1.20e-05 | 2 | 121 | 2 | 25711638 | ||
| Pubmed | 1.20e-05 | 2 | 121 | 2 | 8449034 | ||
| Pubmed | 1.20e-05 | 2 | 121 | 2 | 32777343 | ||
| Pubmed | 1.20e-05 | 2 | 121 | 2 | 9450932 | ||
| Pubmed | TFIP11 interacts with mDEAH9, an RNA helicase involved in spliceosome disassembly. | 1.20e-05 | 2 | 121 | 2 | 19165350 | |
| Pubmed | 1.20e-05 | 2 | 121 | 2 | 29038835 | ||
| Pubmed | 1.20e-05 | 2 | 121 | 2 | 20677832 | ||
| Pubmed | Loss of MLL PHD finger 3 is necessary for MLL-ENL-induced hematopoietic stem cell immortalization. | 1.20e-05 | 2 | 121 | 2 | 18676843 | |
| Pubmed | 1.20e-05 | 2 | 121 | 2 | 9060628 | ||
| Pubmed | 1.20e-05 | 2 | 121 | 2 | 11976948 | ||
| Pubmed | 1.20e-05 | 2 | 121 | 2 | 15981244 | ||
| Pubmed | Evolutionary relationships within a subgroup of HERV-K-related human endogenous retroviruses. | 1.20e-05 | 2 | 121 | 2 | 9460924 | |
| Pubmed | Genetic variants of FZD4 and LRP5 genes in patients with advanced retinopathy of prematurity. | 1.20e-05 | 2 | 121 | 2 | 23441120 | |
| Pubmed | RNA binding induces an allosteric switch in Cyp33 to repress MLL1-mediated transcription. | 1.20e-05 | 2 | 121 | 2 | 37075125 | |
| Pubmed | 1.20e-05 | 2 | 121 | 2 | 10687855 | ||
| Pubmed | 1.20e-05 | 2 | 121 | 2 | 33302760 | ||
| Pubmed | Isolation and characterization of post-splicing lariat-intron complexes. | 1.20e-05 | 2 | 121 | 2 | 19103666 | |
| Pubmed | Protein interactions of the MLL PHD fingers modulate MLL target gene regulation in human cells. | 1.20e-05 | 2 | 121 | 2 | 11313484 | |
| Pubmed | Foxp1 maintains hair follicle stem cell quiescence through regulation of Fgf18. | 1.20e-05 | 2 | 121 | 2 | 23946441 | |
| Pubmed | 1.24e-05 | 403 | 121 | 9 | 35253629 | ||
| Pubmed | Identifying biological pathways that underlie primordial short stature using network analysis. | PDS5B RRP1B CEP290 MYO1B THOC2 NSUN2 TRIP12 DHX30 DHX15 ZC3H11A MDN1 RBM14 UHRF1 PHIP | 1.37e-05 | 1024 | 121 | 14 | 24711643 |
| Pubmed | SHLD2/FAM35A co-operates with REV7 to coordinate DNA double-strand break repair pathway choice. | 1.49e-05 | 150 | 121 | 6 | 30154076 | |
| Pubmed | ASNSD1 CENPC ZDBF2 JADE1 NSUN2 DHX30 ZC3H11A UBN1 DBF4 CHEK2 FAM169A KMT2A FTL BZW1 RBM34 ZNF292 | 1.52e-05 | 1327 | 121 | 16 | 32694731 | |
| Pubmed | STING-Mediated IFI16 Degradation Negatively Controls Type I Interferon Production. | 1.57e-05 | 316 | 121 | 8 | 31665637 | |
| Pubmed | 2.60e-05 | 339 | 121 | 8 | 30415952 | ||
| Pubmed | 2.65e-05 | 340 | 121 | 8 | 29478914 | ||
| Pubmed | The nuclear interactome of DYRK1A reveals a functional role in DNA damage repair. | 3.59e-05 | 106 | 121 | 5 | 31024071 | |
| Pubmed | 3.59e-05 | 3 | 121 | 2 | 18692478 | ||
| Pubmed | 3.59e-05 | 3 | 121 | 2 | 31237656 | ||
| Pubmed | 3.59e-05 | 3 | 121 | 2 | 20489157 | ||
| Pubmed | 3.59e-05 | 3 | 121 | 2 | 30513533 | ||
| Pubmed | 3.59e-05 | 3 | 121 | 2 | 17955262 | ||
| Pubmed | 3.59e-05 | 3 | 121 | 2 | 23287467 | ||
| Pubmed | The RNA m5C Methylase NSUN2 Modulates Corneal Epithelial Wound Healing. | 3.59e-05 | 3 | 121 | 2 | 36862118 | |
| Pubmed | 3.59e-05 | 3 | 121 | 2 | 10516026 | ||
| Pubmed | Molecular Characterization of FZD4, LRP5, and TSPAN12 in Familial Exudative Vitreoretinopathy. | 3.59e-05 | 3 | 121 | 2 | 26244290 | |
| Pubmed | 3.59e-05 | 3 | 121 | 2 | 20301326 | ||
| Pubmed | Delayed re-epithelialization in periostin-deficient mice during cutaneous wound healing. | 3.59e-05 | 3 | 121 | 2 | 21490918 | |
| Pubmed | 3.59e-05 | 3 | 121 | 2 | 22928037 | ||
| Pubmed | 3.59e-05 | 3 | 121 | 2 | 20340138 | ||
| Pubmed | FN1 MLEC LONRF1 POLG CEP290 USP25 MAGI3 TFIP11 FTCD NSUN2 TRIP12 DHX30 N4BP2L2 PCMTD2 ZNF292 | 4.16e-05 | 1285 | 121 | 15 | 35914814 | |
| Pubmed | Genome-wide CRISPR screens identify novel regulators of wild-type and mutant p53 stability. | 4.17e-05 | 588 | 121 | 10 | 38580884 | |
| Pubmed | 4.35e-05 | 591 | 121 | 10 | 15231748 | ||
| Pubmed | Regulation of epidermal differentiation through KDF1-mediated deubiquitination of IKKα. | 4.42e-05 | 182 | 121 | 6 | 32239614 | |
| Pubmed | 4.48e-05 | 20 | 121 | 3 | 36551904 | ||
| Pubmed | Comprehensive analysis of DNA repair gene variants and risk of meningioma. | 4.77e-05 | 57 | 121 | 4 | 18270339 | |
| Pubmed | 5.09e-05 | 114 | 121 | 5 | 31553912 | ||
| Pubmed | 5.13e-05 | 274 | 121 | 7 | 34244482 | ||
| Pubmed | RRP1B TFIP11 POLR1G THOC2 DHX30 DHX15 ZC3H11A RBM14 WDR12 PPIE RBM34 | 5.17e-05 | 731 | 121 | 11 | 29298432 | |
| Pubmed | Mapping the Ku Interactome Using Proximity-Dependent Biotin Identification in Human Cells. | 6.28e-05 | 283 | 121 | 7 | 30585729 | |
| Pubmed | 6.48e-05 | 195 | 121 | 6 | 19454010 | ||
| Pubmed | ALS/FTD-causing mutation in cyclin F causes the dysregulation of SFPQ. | RRP1B NSUN2 TRIP12 TASOR2 DHX30 DHX15 ZGPAT ZC3H11A MDN1 UHRF1 | 6.84e-05 | 624 | 121 | 10 | 33729478 |
| Interaction | POLR1G interactions | PDS5B CENPC RRP1B ATAD5 TOPBP1 CHD7 RFC1 PHF8 POLR1G TRIP12 LARP7 MDN1 CHEK2 KMT2A MPHOSPH10 PHIP RBM34 ZNF292 FGFBP1 | 5.62e-11 | 489 | 117 | 19 | int:POLR1G |
| Interaction | H3C3 interactions | PDS5B RNF168 CENPC RRP1B ATAD5 TOPBP1 CHD7 RFC1 PHF8 TRIP12 FAM169A UHRF1 KMT2A WDR12 CDC27 PHIP RBM34 ZNF292 NPAT | 6.92e-11 | 495 | 117 | 19 | int:H3C3 |
| Interaction | NUP43 interactions | PDS5B EME1 CENPC RRP1B TOPBP1 ZDBF2 RFC1 PHF8 TRIP12 LARP7 TASOR2 HELB RESF1 RBM14 FAM169A KMT2A MPHOSPH10 PHIP ZNF292 NPAT | 5.12e-10 | 625 | 117 | 20 | int:NUP43 |
| Interaction | ZNF330 interactions | PDS5B CENPC RRP1B ATAD5 TOPBP1 CHD7 RFC1 PHF8 TRIP12 LARP7 FAM169A UHRF1 KMT2A CDC27 PHIP RBM34 ZNF292 | 8.50e-10 | 446 | 117 | 17 | int:ZNF330 |
| Interaction | MEN1 interactions | PDS5B KIF13B ERCC6 RRP1B MYO1B TFIP11 RFC1 PHF8 POLR1G THOC2 TRIP12 HORMAD1 DHX30 DHX15 ZC3H11A MDN1 PRCC DBF4 PITX3 RBM14 KMT2A FOXP1 WDR12 MPHOSPH10 RBM34 | 8.58e-10 | 1029 | 117 | 25 | int:MEN1 |
| Interaction | SIRT7 interactions | PDS5B FN1 RRP1B MYO1B CHD7 RFC1 THOC2 NSUN2 TRIP12 LARP7 TASOR2 DHX30 DHX15 ZC3H11A MDN1 KMT2A WDR12 FTL MPHOSPH10 PHIP RBM34 | 1.72e-09 | 744 | 117 | 21 | int:SIRT7 |
| Interaction | SNRNP40 interactions | CENPC RRP1B ATAD5 TFIP11 ZDBF2 RFC1 PHF8 LARP7 TASOR2 ZGPAT UBN1 PRCC PRIM2 RBM14 KMT2A PPIE MPHOSPH10 BZW1 NPAT | 4.61e-09 | 637 | 117 | 19 | int:SNRNP40 |
| Interaction | CENPA interactions | PDS5B ERCC6 CENPC RRP1B ATAD5 CHD7 RFC1 PHF8 THOC2 TRIP12 UHRF1 KMT2A PHIP RBM34 ZNF292 | 5.10e-09 | 377 | 117 | 15 | int:CENPA |
| Interaction | HECTD1 interactions | PDS5B ERCC6 MLEC RRP1B ATAD5 TOPBP1 RFC1 PHF8 POLR1G THOC2 NSUN2 TRIP12 LARP7 DHX30 ZC3H11A MDN1 RBM14 UHRF1 WDR12 MPHOSPH10 BZW1 CDC27 RBM34 | 9.43e-09 | 984 | 117 | 23 | int:HECTD1 |
| Interaction | H3C1 interactions | PDS5B ERCC6 CENPC RRP1B ATAD5 CEP290 CHD7 JADE1 RFC1 PHF8 POLR1G TRIP12 LARP7 UBN1 WDR87 PCDH11X UHRF1 KMT2A CDC27 PHIP RBM34 ZNF292 | 9.52e-09 | 901 | 117 | 22 | int:H3C1 |
| Interaction | H3-3A interactions | PDS5B ERCC6 CENPC RRP1B ATAD5 TOPBP1 CHD7 RFC1 PHF8 TRIP12 CCDC71 UBN1 CTHRC1 UHRF1 KMT2A CDC27 PHIP RBM34 ZNF292 NPAT | 1.12e-08 | 749 | 117 | 20 | int:H3-3A |
| Interaction | TERF2IP interactions | PDS5B SP100 CENPC ATAD5 TOPBP1 CHD7 RFC1 THOC2 TRIP12 LARP7 TASOR2 ZGPAT ZC3H11A PRCC KMT2A ZNF292 NPAT | 2.04e-08 | 552 | 117 | 17 | int:TERF2IP |
| Interaction | SMC5 interactions | PDS5B CENPC RRP1B ATAD5 TOPBP1 TFIP11 ZDBF2 CHD7 RFC1 THOC2 SSX1 TRIP12 TASOR2 DHX15 ZC3H11A UBN1 PRCC RBM14 KMT2A MPHOSPH10 PHIP NPAT | 6.09e-08 | 1000 | 117 | 22 | int:SMC5 |
| Interaction | H2BC8 interactions | PDS5B EME1 CENPC ATAD5 POLG TOPBP1 CHD7 RFC1 TRIP12 PRCC FAM169A UHRF1 KMT2A PHIP RBM34 ZNF292 | 2.25e-07 | 576 | 117 | 16 | int:H2BC8 |
| Interaction | H2BC21 interactions | PDS5B EME1 RNF168 ATAD5 CHD7 JADE1 RFC1 PHF8 TRIP12 LARP7 DHX15 CCDC71 UHRF1 KMT2A CDC27 PHIP ZNF292 | 5.56e-07 | 696 | 117 | 17 | int:H2BC21 |
| Interaction | NCL interactions | ERCC6 RNF168 FN1 RRP1B USP25 RFC1 POLR1G NSUN2 IFIT1 LARP7 TASOR2 DHX30 DHX15 WDR87 KMT2A PPIE CDC27 FGFBP1 | 7.91e-07 | 798 | 117 | 18 | int:NCL |
| Interaction | NLE1 interactions | CENPC RRP1B TOPBP1 DHX15 MDN1 RBM14 WDR12 MPHOSPH10 RBM34 NPAT | 8.75e-07 | 228 | 117 | 10 | int:NLE1 |
| Interaction | DOT1L interactions | ERCC6 RRP1B MYO1B TFIP11 RFC1 POLR1G THOC2 TRIP12 LARP7 DHX30 DHX15 ZC3H11A MDN1 KMT2A FOXP1 WDR12 MPHOSPH10 RBM34 | 9.29e-07 | 807 | 117 | 18 | int:DOT1L |
| Interaction | POLR1E interactions | CENPC RRP1B ATAD5 ZDBF2 CHD7 PHF8 POLR1G MDN1 KMT2A MPHOSPH10 RBM34 ZNF292 | 9.33e-07 | 350 | 117 | 12 | int:POLR1E |
| Interaction | BRD3 interactions | PDS5B CENPC RRP1B ATAD5 RFC1 PHF8 POLR1G THOC2 TRIP12 LARP7 UHRF1 KMT2A CDC27 PHIP | 1.08e-06 | 494 | 117 | 14 | int:BRD3 |
| Interaction | ASF1A interactions | 1.94e-06 | 249 | 117 | 10 | int:ASF1A | |
| Interaction | FGFBP1 interactions | RRP1B RFC1 POLR1G TRIP12 LARP7 DHX30 KMT2A MPHOSPH10 RBM34 FGFBP1 | 2.58e-06 | 257 | 117 | 10 | int:FGFBP1 |
| Interaction | PRKRA interactions | CENPC RRP1B RFC1 TRIP12 LARP7 DHX30 KMT2A WDR12 PPIE MPHOSPH10 RBM34 FGFBP1 | 3.72e-06 | 400 | 117 | 12 | int:PRKRA |
| Interaction | H2BC3 interactions | PDS5B ERCC6 RNF168 ATAD5 CHD7 RFC1 TRIP12 LARP7 MDN1 UHRF1 KMT2A CDC27 | 4.34e-06 | 406 | 117 | 12 | int:H2BC3 |
| Interaction | OBSL1 interactions | PDS5B RRP1B RFC1 PHF8 POLR1G THOC2 TRIP12 LARP7 TASOR2 DHX30 DHX15 ZC3H11A MDN1 RBM14 UHRF1 WDR12 PHIP RBM34 | 4.46e-06 | 902 | 117 | 18 | int:OBSL1 |
| Interaction | CBX3 interactions | PDS5B SP100 FN1 CENPC ATAD5 TOPBP1 CHD7 RFC1 TRIP12 CCDC71 PRCC UHRF1 KMT2A PHIP ZNF292 | 5.06e-06 | 646 | 117 | 15 | int:CBX3 |
| Interaction | NIFK interactions | CENPC RRP1B ATAD5 RFC1 PHF8 POLR1G LARP7 MDN1 WDR12 MPHOSPH10 RBM34 FGFBP1 | 7.94e-06 | 431 | 117 | 12 | int:NIFK |
| Interaction | TOP2A interactions | PDS5B ERCC6 RNF168 FN1 RFC1 POLR1G DHX30 RESF1 PRIM2 UHRF1 FOXP1 FTL BZW1 | 1.04e-05 | 520 | 117 | 13 | int:TOP2A |
| Interaction | SENP3 interactions | 1.04e-05 | 301 | 117 | 10 | int:SENP3 | |
| Interaction | SNRNP70 interactions | FN1 RRP1B USP25 TFIP11 FTCD RFC1 THOC2 NSUN2 IFIT1 LARP7 DHX30 DHX15 ZC3H11A FOXP1 WDR12 MPHOSPH10 BZW1 RBM34 | 1.46e-05 | 984 | 117 | 18 | int:SNRNP70 |
| Interaction | FBXO22 interactions | BDP1 PDS5B CACNA1C ERCC6 FN1 TFIP11 TRIP12 MDN1 CHEK2 KMT2A WDR12 RBM34 ZNF292 | 1.55e-05 | 540 | 117 | 13 | int:FBXO22 |
| Interaction | NR2C2 interactions | PDS5B RRP1B TFIP11 CHD7 RFC1 POLR1G THOC2 NSUN2 TRIP12 LARP7 DHX30 DHX15 MDN1 CCDC71 UBN1 KMT2A WDR12 MPHOSPH10 BZW1 CDC27 PHIP RBM34 | 1.67e-05 | 1403 | 117 | 22 | int:NR2C2 |
| Interaction | USP7 interactions | CACNA1C ERCC6 RNF168 FAT3 MYO1B TFIP11 ZDBF2 RFC1 PHF8 POLR1G THOC2 TRIP12 DHX30 DHX15 ZC3H11A MDN1 UBN1 CHEK2 RBM14 UHRF1 PHIP | 2.00e-05 | 1313 | 117 | 21 | int:USP7 |
| Interaction | PARP1 interactions | PDS5B ERCC6 RNF168 FN1 CENPC RRP1B ATAD5 TOPBP1 CHD7 RFC1 PHF8 TRIP12 LARP7 MDN1 RBM14 FAM169A UHRF1 MPHOSPH10 PHIP RBM34 ZNF292 | 2.07e-05 | 1316 | 117 | 21 | int:PARP1 |
| Interaction | NOP56 interactions | ERCC6 CENPC RRP1B ATAD5 RFC1 PHF8 POLR1G LARP7 DHX30 DHX15 MPHOSPH10 RBM34 FGFBP1 | 2.72e-05 | 570 | 117 | 13 | int:NOP56 |
| Interaction | H1-4 interactions | SP100 RRP1B RFC1 PHF8 LARP7 TASOR2 DHX30 ZC3H11A WDR87 KMT2A FOXP1 WDR12 MPHOSPH10 RBM34 | 2.73e-05 | 656 | 117 | 14 | int:H1-4 |
| Interaction | ALYREF interactions | FN1 RRP1B POLR1G THOC2 TRIP12 LARP7 ZC3H11A UHRF1 FOXP1 PPIE RBM34 | 3.10e-05 | 416 | 117 | 11 | int:ALYREF |
| Interaction | SNRPD1 interactions | 3.51e-05 | 347 | 117 | 10 | int:SNRPD1 | |
| Interaction | H2AC4 interactions | PDS5B ERCC6 RNF168 RRP1B ATAD5 RFC1 TRIP12 LARP7 ADGB MDN1 KMT2A WDR12 | 3.87e-05 | 506 | 117 | 12 | int:H2AC4 |
| Interaction | SUMO2 interactions | EME1 SP100 ERCC6 RNF168 CENPC USP25 PHF8 NSUN2 TRIP12 ZC3H11A MDN1 PPIE BZW1 | 3.95e-05 | 591 | 117 | 13 | int:SUMO2 |
| Interaction | PRPF8 interactions | ERCC6 FN1 KRT34 TFIP11 THOC2 NSUN2 LARP7 DHX30 DHX15 ZGPAT PRCC RBM14 UHRF1 FTL PPIE | 4.34e-05 | 776 | 117 | 15 | int:PRPF8 |
| Interaction | SNRPA1 interactions | 6.45e-05 | 300 | 117 | 9 | int:SNRPA1 | |
| Interaction | CSNK2B interactions | ERCC6 FN1 RRP1B TFIP11 JADE1 RFC1 PHF8 LARP7 CHEK2 KMT2A WDR12 MPHOSPH10 SMG6 | 6.99e-05 | 625 | 117 | 13 | int:CSNK2B |
| Interaction | SNRPE interactions | 7.32e-05 | 305 | 117 | 9 | int:SNRPE | |
| Interaction | H1-5 interactions | DENND2A FN1 CENPC ZDBF2 PHF8 LARP7 TASOR2 DHX30 ADGB WDR87 MPHOSPH10 | 8.13e-05 | 463 | 117 | 11 | int:H1-5 |
| Interaction | SET interactions | 8.50e-05 | 311 | 117 | 9 | int:SET | |
| Interaction | DGCR8 interactions | 8.52e-05 | 242 | 117 | 8 | int:DGCR8 | |
| Interaction | LHX2 interactions | 9.71e-05 | 183 | 117 | 7 | int:LHX2 | |
| Interaction | DCPS interactions | 1.01e-04 | 394 | 117 | 10 | int:DCPS | |
| Interaction | DHX40 interactions | 1.04e-04 | 249 | 117 | 8 | int:DHX40 | |
| Interaction | DDX23 interactions | PDS5B ERCC6 CENPC RRP1B TFIP11 PHF8 THOC2 LARP7 ZGPAT MPHOSPH10 RBM34 | 1.12e-04 | 480 | 117 | 11 | int:DDX23 |
| Interaction | SOX7 interactions | 1.16e-04 | 82 | 117 | 5 | int:SOX7 | |
| Interaction | SRSF1 interactions | FN1 RRP1B TRIP12 LARP7 DHX30 DHX15 RBM14 FOXP1 MPHOSPH10 BZW1 RBM34 SMG6 | 1.20e-04 | 570 | 117 | 12 | int:SRSF1 |
| Interaction | APEX1 interactions | PDS5B CENPC RRP1B ATAD5 POLG CEP290 TOPBP1 ELOVL1 CHD7 RFC1 PHF8 THOC2 TRIP12 ZGPAT ZFR2 FAM169A UHRF1 KMT2A ZNF292 | 1.28e-04 | 1271 | 117 | 19 | int:APEX1 |
| Interaction | KDF1 interactions | 1.31e-04 | 192 | 117 | 7 | int:KDF1 | |
| Interaction | RPL4 interactions | FN1 CENPC RRP1B USP25 POLR1G TRIP12 LARP7 DHX30 FOXP1 WDR12 PPIE MPHOSPH10 RBM34 FGFBP1 | 1.39e-04 | 764 | 117 | 14 | int:RPL4 |
| Interaction | PRDM16 interactions | 1.44e-04 | 195 | 117 | 7 | int:PRDM16 | |
| Interaction | PCNA interactions | PDS5B ERCC6 FN1 ATAD5 RFC1 DHX15 PRIM2 UHRF1 PPIE CDC27 REV1 | 1.52e-04 | 497 | 117 | 11 | int:PCNA |
| Interaction | SNRPD2 interactions | 1.52e-04 | 414 | 117 | 10 | int:SNRPD2 | |
| Interaction | ASH2L interactions | 1.59e-04 | 265 | 117 | 8 | int:ASH2L | |
| Interaction | RPS6 interactions | PDS5B ERCC6 FN1 CENPC RRP1B USP25 RFC1 NSUN2 LARP7 DHX30 WDR12 PPIE MPHOSPH10 PHIP RBM34 | 1.63e-04 | 874 | 117 | 15 | int:RPS6 |
| Interaction | H2BC17 interactions | 1.68e-04 | 140 | 117 | 6 | int:H2BC17 | |
| Interaction | RPL36 interactions | FN1 CENPC RRP1B LARP7 DHX30 DHX15 KMT2A WDR12 MPHOSPH10 ATP2B4 RBM34 | 1.71e-04 | 504 | 117 | 11 | int:RPL36 |
| Interaction | SSRP1 interactions | JADE1 RFC1 POLR1G LARP7 ZC3H11A CCDC71 PRIM2 RBM14 UHRF1 KMT2A PPIE PHIP FGFBP1 | 1.74e-04 | 685 | 117 | 13 | int:SSRP1 |
| Interaction | BCAS2 interactions | 1.81e-04 | 270 | 117 | 8 | int:BCAS2 | |
| Interaction | SOX2 interactions | FN1 RRP1B ATAD5 ELOVL1 MYO1B TFIP11 ZDBF2 CHD7 RFC1 TRIP12 LARP7 DHX30 DHX15 MDN1 RBM14 KMT2A FOXP1 RBM34 ZNF292 SMG6 | 1.89e-04 | 1422 | 117 | 20 | int:SOX2 |
| Interaction | HNRNPCL2 interactions | 2.00e-04 | 274 | 117 | 8 | int:HNRNPCL2 | |
| Interaction | NEIL1 interactions | 2.10e-04 | 276 | 117 | 8 | int:NEIL1 | |
| Interaction | RPL5 interactions | ERCC6 FN1 RRP1B RFC1 POLR1G NSUN2 LARP7 DHX30 FOXP1 CDC27 RBM34 FGFBP1 | 2.12e-04 | 606 | 117 | 12 | int:RPL5 |
| Interaction | LINC02910 interactions | 2.31e-04 | 95 | 117 | 5 | int:LINC02910 | |
| Interaction | CHTOP interactions | 2.41e-04 | 212 | 117 | 7 | int:CHTOP | |
| Interaction | PKD1 interactions | 2.54e-04 | 53 | 117 | 4 | int:PKD1 | |
| Interaction | IFI16 interactions | SP100 RRP1B RFC1 NSUN2 TRIP12 LARP7 DHX30 DHX15 RBM14 WDR12 MPHOSPH10 PHIP RBM34 | 2.60e-04 | 714 | 117 | 13 | int:IFI16 |
| Interaction | GTPBP4 interactions | SP100 FN1 RRP1B POLR1G NSUN2 LARP7 WDR12 MPHOSPH10 RBM34 FGFBP1 | 2.61e-04 | 443 | 117 | 10 | int:GTPBP4 |
| Interaction | IK interactions | 2.62e-04 | 215 | 117 | 7 | int:IK | |
| Interaction | SRPK2 interactions | RRP1B MYO1B TFIP11 TRIP12 LARP7 DHX30 DHX15 CHEK2 WDR12 DNAH6 RBM34 NCK2 FGFBP1 | 2.71e-04 | 717 | 117 | 13 | int:SRPK2 |
| Interaction | HDAC11 interactions | 2.81e-04 | 154 | 117 | 6 | int:HDAC11 | |
| Interaction | RPL3 interactions | FN1 CENPC RRP1B POLR1G TRIP12 LARP7 DHX30 KMT2A WDR12 PPIE MPHOSPH10 RBM34 FGFBP1 | 2.90e-04 | 722 | 117 | 13 | int:RPL3 |
| Interaction | SLU7 interactions | 3.01e-04 | 156 | 117 | 6 | int:SLU7 | |
| Interaction | RPL8 interactions | SP100 FN1 RRP1B CHD7 NSUN2 LARP7 DHX30 PPIE MPHOSPH10 RBM34 FGFBP1 | 3.05e-04 | 539 | 117 | 11 | int:RPL8 |
| Interaction | BRCA1 interactions | EME1 ERCC6 RNF168 LONRF1 TOPBP1 RFC1 HORMAD1 LARP7 DHX15 ZC3H11A MDN1 DBF4 CHEK2 RBM14 UHRF1 PCMTD2 CDC27 REV1 | 3.08e-04 | 1249 | 117 | 18 | int:BRCA1 |
| Interaction | E2F4 interactions | ERCC6 RFC1 POLR1G TASOR2 DHX30 ZC3H11A UBN1 UHRF1 KMT2A PPIE MPHOSPH10 | 3.10e-04 | 540 | 117 | 11 | int:E2F4 |
| Interaction | TRIM31 interactions | 3.18e-04 | 454 | 117 | 10 | int:TRIM31 | |
| Interaction | HNRNPU interactions | EME1 ERCC6 FN1 CENPC RRP1B CEP290 RFC1 PHF8 LARP7 DHX30 DHX15 CHEK2 RBM14 UHRF1 PPIE RBM34 | 3.18e-04 | 1035 | 117 | 16 | int:HNRNPU |
| Interaction | PML interactions | EME1 SP100 ERCC6 MAMLD1 TOPBP1 THOC2 DHX15 ZC3H11A MDN1 UBN1 PRCC CHEK2 UHRF1 KMT2A PHIP | 3.29e-04 | 933 | 117 | 15 | int:PML |
| Interaction | MYCN interactions | PDS5B RRP1B MYO1B TFIP11 CHD7 POLR1G THOC2 NSUN2 LARP7 DHX30 DHX15 ZC3H11A RBM14 UHRF1 KMT2A PPIE MPHOSPH10 RBM34 SMG6 | 3.43e-04 | 1373 | 117 | 19 | int:MYCN |
| Interaction | AATF interactions | RRP1B MYO1B POLR1G THOC2 NSUN2 ZC3H11A CHEK2 MPHOSPH10 FGFBP1 | 3.50e-04 | 376 | 117 | 9 | int:AATF |
| Interaction | ZC3H3 interactions | 3.55e-04 | 226 | 117 | 7 | int:ZC3H3 | |
| Interaction | PPP1CC interactions | ASNSD1 RRP1B TOPBP1 MYO1B ZDBF2 DYRK4 LARP7 DHX30 DHX15 RBM14 FTL RBM34 SMG6 | 3.57e-04 | 738 | 117 | 13 | int:PPP1CC |
| Interaction | KRR1 interactions | 3.71e-04 | 379 | 117 | 9 | int:KRR1 | |
| Interaction | COIL interactions | PDS5B CENPC CHD7 PHF8 POLR1G LARP7 DHX30 ADAMTS12 RBM34 ZNF292 NPAT | 3.73e-04 | 552 | 117 | 11 | int:COIL |
| Interaction | BRCA2 interactions | 4.08e-04 | 384 | 117 | 9 | int:BRCA2 | |
| Interaction | SNRPF interactions | 4.15e-04 | 385 | 117 | 9 | int:SNRPF | |
| Interaction | CSNK2A1 interactions | DTD1 BDP1 FN1 RRP1B ATAD5 MYO1B POLR1G LARP7 DHX15 PRCC CHEK2 KMT2A WDR12 MPHOSPH10 RBM34 | 4.25e-04 | 956 | 117 | 15 | int:CSNK2A1 |
| Interaction | MUS81 interactions | 4.37e-04 | 109 | 117 | 5 | int:MUS81 | |
| Interaction | HDLBP interactions | FN1 TOPBP1 TFIP11 CHD7 RFC1 THOC2 LARP7 DHX15 RRAGD RBM14 UHRF1 KMT2A FTL RBM34 | 4.39e-04 | 855 | 117 | 14 | int:HDLBP |
| Interaction | FUBP1 interactions | 4.48e-04 | 309 | 117 | 8 | int:FUBP1 | |
| Interaction | NEK3 interactions | 4.50e-04 | 26 | 117 | 3 | int:NEK3 | |
| Interaction | GRWD1 interactions | 4.56e-04 | 390 | 117 | 9 | int:GRWD1 | |
| Interaction | KRT4 interactions | 4.64e-04 | 62 | 117 | 4 | int:KRT4 | |
| Cytoband | Ensembl 112 genes in cytogenetic band chr6p11 | 3.01e-04 | 10 | 120 | 2 | chr6p11 | |
| Cytoband | 8p23.1 | 7.39e-04 | 154 | 120 | 4 | 8p23.1 | |
| Cytoband | Ensembl 112 genes in cytogenetic band chr13q13 | 1.33e-03 | 82 | 120 | 3 | chr13q13 | |
| Cytoband | Ensembl 112 genes in cytogenetic band chr2q33 | 2.12e-03 | 205 | 120 | 4 | chr2q33 | |
| Cytoband | 2q33 | 2.63e-03 | 29 | 120 | 2 | 2q33 | |
| Cytoband | 22q12.1 | 3.19e-03 | 32 | 120 | 2 | 22q12.1 | |
| Cytoband | 20p11.23 | 3.60e-03 | 34 | 120 | 2 | 20p11.23 | |
| GeneFamily | PHD finger proteins | 3.36e-05 | 90 | 74 | 5 | 88 | |
| GeneFamily | Zinc fingers DBF-type | 4.94e-05 | 3 | 74 | 2 | 75 | |
| GeneFamily | Zinc fingers CCCH-type | 3.92e-04 | 35 | 74 | 3 | 73 | |
| GeneFamily | AAA ATPases | 1.33e-03 | 53 | 74 | 3 | 413 | |
| GeneFamily | RNA binding motif containing | 1.80e-03 | 213 | 74 | 5 | 725 | |
| GeneFamily | DEAH-box helicases | 1.91e-03 | 16 | 74 | 2 | 500 | |
| GeneFamily | G-patch domain containing|Minor histocompatibility antigens | 3.62e-03 | 22 | 74 | 2 | 579 | |
| GeneFamily | DNA polymerases | 3.95e-03 | 23 | 74 | 2 | 535 | |
| GeneFamily | Armadillo repeat containing|Protein phosphatase 1 regulatory subunits | 6.48e-03 | 181 | 74 | 4 | 694 | |
| Coexpression | DACOSTA_UV_RESPONSE_VIA_ERCC3_DN | PDS5B SP100 CENPC MAMLD1 TOPBP1 MYO1B PHF8 THOC2 TRIP12 DHX15 MDN1 DBF4 MTFR1 PRIM2 FAM169A N4BP2L2 CDC27 ATP2B4 PHIP ZNF292 NPAT | 1.42e-10 | 856 | 115 | 21 | M4500 |
| Coexpression | GSE360_DC_VS_MAC_L_MAJOR_DN | 2.83e-06 | 199 | 115 | 8 | M5182 | |
| Coexpression | HAMAI_APOPTOSIS_VIA_TRAIL_UP | BDP1 PDS5B CENPC CEP290 USP25 RFC1 LARP7 TASOR2 RESF1 DBF4 CTHRC1 N4BP2L2 MPHOSPH10 | 6.33e-06 | 656 | 115 | 13 | M18979 |
| Coexpression | DACOSTA_UV_RESPONSE_VIA_ERCC3_COMMON_DN | MAMLD1 TOPBP1 MYO1B TRIP12 DHX15 MDN1 PRIM2 FAM169A CDC27 PHIP ZNF292 | 6.74e-06 | 466 | 115 | 11 | M13522 |
| Coexpression | LEE_BMP2_TARGETS_DN | PDE3B MLEC RRP1B ATAD5 TOPBP1 NSUN2 MDN1 PTPRG DBF4 MTFR1 GSTCD UHRF1 WDR12 MPHOSPH10 BZW1 | 9.99e-06 | 904 | 115 | 15 | M2325 |
| Coexpression | LEE_BMP2_TARGETS_DN | PDE3B MLEC RRP1B ATAD5 TOPBP1 NSUN2 MDN1 PTPRG DBF4 MTFR1 GSTCD UHRF1 WDR12 MPHOSPH10 BZW1 | 1.26e-05 | 922 | 115 | 15 | MM1068 |
| Coexpression | RODRIGUES_THYROID_CARCINOMA_ANAPLASTIC_UP | SP100 FN1 TOPBP1 RFC1 THOC2 RESF1 DBF4 PRIM2 CTHRC1 MPHOSPH10 BZW1 PHIP RBM34 | 1.72e-05 | 721 | 115 | 13 | M10237 |
| Coexpression | FISCHER_DREAM_TARGETS | PDS5B EME1 CENPC ATAD5 TOPBP1 JADE1 RFC1 LARP7 DHX15 DBF4 PRIM2 GSTCD CHEK2 UHRF1 NPAT | 2.25e-05 | 969 | 115 | 15 | M149 |
| Coexpression | GSE360_L_MAJOR_VS_M_TUBERCULOSIS_DC_DN | 2.87e-05 | 199 | 115 | 7 | M5214 | |
| Coexpression | GSE26890_CXCR1_NEG_VS_POS_EFFECTOR_CD8_TCELL_UP | 2.96e-05 | 200 | 115 | 7 | M8559 | |
| Coexpression | GSE44649_NAIVE_VS_ACTIVATED_CD8_TCELL_MIR155_KO_DN | 2.96e-05 | 200 | 115 | 7 | M9777 | |
| Coexpression | PUJANA_CHEK2_PCC_NETWORK | SP100 CENPC RRP1B POLG TOPBP1 LARP7 DHX15 DBF4 CHEK2 RBM14 MPHOSPH10 BZW1 RBM34 | 3.02e-05 | 761 | 115 | 13 | M11961 |
| Coexpression | KAUFFMANN_DNA_REPLICATION_GENES | 4.60e-05 | 146 | 115 | 6 | M9372 | |
| Coexpression | KINSEY_TARGETS_OF_EWSR1_FLII_FUSION_UP | RAB23 PDS5B KIF13B EME1 RRP1B ATAD5 LONRF1 JADE1 RFC1 DHX15 DBF4 MTFR1 PRIM2 CHEK2 RBM14 UHRF1 BZW1 | 4.75e-05 | 1290 | 115 | 17 | M80 |
| Coexpression | GOBERT_OLIGODENDROCYTE_DIFFERENTIATION_UP | EME1 FN1 MLEC RRP1B ATAD5 JADE1 LARP7 DBF4 PRIM2 CHEK2 UHRF1 | 4.90e-05 | 578 | 115 | 11 | M2368 |
| Coexpression | HE_LIM_SUN_FETAL_LUNG_C4_CYCLING_NK_CELL | PDS5B EME1 RNF168 ATAD5 TOPBP1 JADE1 DBF4 PRIM2 CHEK2 RBM14 UHRF1 CDC27 | 5.54e-05 | 694 | 115 | 12 | M45767 |
| Coexpression | GOBERT_OLIGODENDROCYTE_DIFFERENTIATION_UP | EME1 FN1 MLEC RRP1B ATAD5 JADE1 LARP7 DBF4 PRIM2 CHEK2 UHRF1 | 6.54e-05 | 597 | 115 | 11 | MM1309 |
| Coexpression | KAUFFMANN_DNA_REPAIR_GENES | 7.17e-05 | 230 | 115 | 7 | M11563 | |
| Coexpression | HE_LIM_SUN_FETAL_LUNG_C5_LARGE_PRE_B_CELL | ASNSD1 PDS5B RNF168 MLEC RRP1B ATAD5 TOPBP1 JADE1 RFC1 UBN1 DBF4 PRIM2 CHEK2 UHRF1 PPIE CDC27 REV1 | 9.34e-05 | 1363 | 115 | 17 | M45782 |
| Coexpression | DANG_REGULATED_BY_MYC_DN | 1.24e-04 | 251 | 115 | 7 | M2310 | |
| Coexpression | ZHANG_BREAST_CANCER_PROGENITORS_UP | 1.29e-04 | 434 | 115 | 9 | M15150 | |
| Coexpression | GSE25146_UNSTIM_VS_HELIOBACTER_PYLORI_LPS_STIM_AGS_CELL_UP | 1.46e-04 | 180 | 115 | 6 | M8127 | |
| Coexpression | ZHANG_BREAST_CANCER_PROGENITORS_UP | 1.63e-04 | 448 | 115 | 9 | MM1044 | |
| Coexpression | FEVR_CTNNB1_TARGETS_DN | 1.71e-04 | 555 | 115 | 10 | M2343 | |
| Coexpression | NAKAYA_PLASMACYTOID_DENDRITIC_CELL_FLUMIST_AGE_18_50YO_7DY_DN | RAB23 DENND2A STARD8 FN1 POLG RFC1 CCDC71 ZFR2 MTFR1 CSNK1G1 FOXP1 ZNF292 NPAT | 1.80e-04 | 909 | 115 | 13 | M41018 |
| Coexpression | HE_LIM_SUN_FETAL_LUNG_C1_EARLY_STALK_CELL | 2.03e-04 | 567 | 115 | 10 | M45692 | |
| Coexpression | GSE8515_CTRL_VS_IL6_4H_STIM_MAC_DN | 2.26e-04 | 195 | 115 | 6 | M5765 | |
| Coexpression | GSE32986_GMCSF_VS_GMCSF_AND_CURDLAN_LOWDOSE_STIM_DC_DN | 2.38e-04 | 197 | 115 | 6 | M8611 | |
| Coexpression | HE_LIM_SUN_FETAL_LUNG_C4_CYCLING_T_CELL | PDS5B PDE3B RNF168 ATAD5 TOPBP1 CHD7 JADE1 DBF4 PRIM2 CHEK2 UHRF1 CDC27 NPAT | 2.47e-04 | 939 | 115 | 13 | M45768 |
| Coexpression | GSE7460_FOXP3_MUT_VS_HET_ACT_TCONV_DN | 2.52e-04 | 199 | 115 | 6 | M5707 | |
| Coexpression | GSE411_WT_VS_SOCS3_KO_MACROPHAGE_IL6_STIM_100MIN_DN | 2.58e-04 | 200 | 115 | 6 | M5993 | |
| Coexpression | GSE22601_IMMATURE_CD4_SINGLE_POSITIVE_VS_DOUBLE_POSITIVE_THYMOCYTE_DN | 2.58e-04 | 200 | 115 | 6 | M6247 | |
| Coexpression | GSE37533_PPARG1_FOXP3_VS_PPARG2_FOXP3_TRANSDUCED_CD4_TCELL_DN | 2.58e-04 | 200 | 115 | 6 | M8997 | |
| Coexpression | GSE360_CTRL_VS_B_MALAYI_LOW_DOSE_MAC_UP | 2.58e-04 | 200 | 115 | 6 | M5168 | |
| Coexpression | GSE3982_EFF_MEMORY_CD4_TCELL_VS_TH2_DN | 2.58e-04 | 200 | 115 | 6 | M5582 | |
| Coexpression | GSE22886_UNSTIM_VS_STIM_MEMORY_TCELL_DN | 2.58e-04 | 200 | 115 | 6 | M4410 | |
| Coexpression | GSE20198_IL12_IL18_VS_IFNA_TREATED_ACT_CD4_TCELL_DN | 2.58e-04 | 200 | 115 | 6 | M7369 | |
| Coexpression | GSE20198_IL12_VS_IL12_IL18_TREATED_ACT_CD4_TCELL_DN | 2.58e-04 | 200 | 115 | 6 | M7372 | |
| Coexpression | BUSSLINGER_GASTRIC_IMMUNE_CELLS | BDP1 PDS5B ARPP19 CENPC USP25 JADE1 TRIP12 ZC3H6 ZC3H11A RESF1 KMT2A N4BP2L2 BZW1 ATP2B4 PHIP ZNF292 NPAT | 2.74e-04 | 1492 | 115 | 17 | M40023 |
| Coexpression | PAL_PRMT5_TARGETS_UP | 2.87e-04 | 204 | 115 | 6 | M10688 | |
| Coexpression | WHITFIELD_CELL_CYCLE_G1_S | 3.06e-04 | 133 | 115 | 5 | M2074 | |
| Coexpression | TURASHVILI_BREAST_LOBULAR_CARCINOMA_VS_LOBULAR_NORMAL_DN | 3.19e-04 | 74 | 115 | 4 | M13547 | |
| Coexpression | PAL_PRMT5_TARGETS_UP | 3.35e-04 | 210 | 115 | 6 | MM1172 | |
| Coexpression | SENESE_HDAC3_TARGETS_UP | 3.41e-04 | 495 | 115 | 9 | M8451 | |
| Coexpression | GSE12003_4D_VS_8D_CULTURE_BM_PROGENITOR_DN | 3.51e-04 | 137 | 115 | 5 | M406 | |
| Coexpression | NAKAYA_MYELOID_DENDRITIC_CELL_FLUARIX_FLUVIRIN_AGE_18_50YO_7DY_UP | 3.86e-04 | 399 | 115 | 8 | M41172 | |
| CoexpressionAtlas | FacebaseRNAseq_e8.5_Hind Brain Neural Epithelium_top-relative-expression-ranked_2500_k-means-cluster#3 | BDP1 EME1 PDE3B ERCC6 CENPC ATAD5 POLG CEP290 USP25 MAGI3 ZDBF2 CHD7 JADE1 LARP7 DBF4 FAM169A MPHOSPH10 PHIP | 4.93e-10 | 532 | 114 | 18 | Facebase_RNAseq_e8.5_Hind Brain Neural Epithelium_2500_K3 |
| CoexpressionAtlas | FacebaseRNAseq_e10.5_Neural Epithelium Overlying Lateral Eminence_top-relative-expression-ranked_500_k-means-cluster#5 | BDP1 EME1 RNF168 ATAD5 FAT3 CEP290 MAMLD1 ZDBF2 CHD7 DBF4 MPHOSPH10 PHIP | 4.51e-09 | 232 | 114 | 12 | Facebase_RNAseq_e10.5_Neural Epithelium Overlying Lateral Eminence_500_K5 |
| CoexpressionAtlas | FacebaseRNAseq_e10.5_Neural Epithelium Flanking Eminence_top-relative-expression-ranked_1000 | BDP1 EME1 SP100 RNF168 ATAD5 FAT3 CEP290 MAMLD1 ZDBF2 CHD7 POLR1G NSUN2 RRAGD DBF4 GSTCD PCDH11X FAM169A UHRF1 N4BP2L2 MPHOSPH10 PHIP ZNF292 | 1.22e-08 | 989 | 114 | 22 | Facebase_RNAseq_e10.5_Neural Epithelium Flanking Eminence_1000 |
| CoexpressionAtlas | FacebaseRNAseq_e10.5_Neural Epithelium Flanking Eminence_top-relative-expression-ranked_500_k-means-cluster#3 | BDP1 EME1 RNF168 ATAD5 CEP290 MAMLD1 ZDBF2 CHD7 MPHOSPH10 PHIP | 8.71e-08 | 192 | 114 | 10 | Facebase_RNAseq_e10.5_Neural Epithelium Flanking Eminence_500_K3 |
| CoexpressionAtlas | facebase_RNAseq_e8.5_NeuroEpith_hindBrain_2500_K1 | EME1 PDE3B MLEC RRP1B ATAD5 CEP290 ZDBF2 CHD7 BCAS1 JADE1 RFC1 POLR1G FGF18 LARP7 DHX15 MDN1 RRAGD DBF4 FAM169A CTHRC1 UHRF1 MPHOSPH10 | 2.13e-07 | 1164 | 114 | 22 | facebase_RNAseq_e8.5_NeuroEpith_hindBrain_2500_K1 |
| CoexpressionAtlas | FacebaseRNAseq_e10.5_Neural Epithelium Overlying Lateral Eminence_top-relative-expression-ranked_1000 | BDP1 EME1 PDE3B RNF168 ATAD5 FAT3 CEP290 MAMLD1 USP25 ZDBF2 CHD7 JADE1 POSTN MDN1 DBF4 ZFR2 PCDH11X FAM169A MPHOSPH10 PHIP | 2.60e-07 | 983 | 114 | 20 | Facebase_RNAseq_e10.5_Neural Epithelium Overlying Lateral Eminence_1000 |
| CoexpressionAtlas | FacebaseRNAseq_e9.5_Mandibular Arch_top-relative-expression-ranked_2500_k-means-cluster#2 | BDP1 PDS5B EME1 PDE3B RNF168 ATAD5 TOPBP1 CHD7 THOC2 ZC3H11A DBF4 GSTCD CHEK2 ZNF292 NPAT | 3.55e-07 | 564 | 114 | 15 | Facebase_RNAseq_e9.5_Mandibular Arch_2500_K2 |
| CoexpressionAtlas | FacebaseRNAseq_e10.5_Neural Epithelium Overlying Lateral Eminence_top-relative-expression-ranked_500 | BDP1 EME1 RNF168 ATAD5 FAT3 CEP290 MAMLD1 USP25 ZDBF2 CHD7 DBF4 FAM169A MPHOSPH10 PHIP | 4.13e-07 | 493 | 114 | 14 | Facebase_RNAseq_e10.5_Neural Epithelium Overlying Lateral Eminence_500 |
| CoexpressionAtlas | FacebaseRNAseq_e9.5_Mandibular Arch_top-relative-expression-ranked_500_k-means-cluster#5 | 4.37e-07 | 29 | 114 | 5 | Facebase_RNAseq_e9.5_Mandibular Arch_500_K5 | |
| CoexpressionAtlas | FacebaseRNAseq_e10.5_Neural Epithelium Flanking Eminence_top-relative-expression-ranked_500 | BDP1 EME1 RNF168 ATAD5 FAT3 CEP290 MAMLD1 ZDBF2 CHD7 POLR1G RRAGD FAM169A MPHOSPH10 PHIP | 4.66e-07 | 498 | 114 | 14 | Facebase_RNAseq_e10.5_Neural Epithelium Flanking Eminence_500 |
| CoexpressionAtlas | facebase_RNAseq_e10.5_MandArch_2500_K1 | ASNSD1 CACNA1C EME1 PDE3B CENPC RRP1B ATAD5 CEP290 ZDBF2 CHD7 THOC2 DHX30 MDN1 RESF1 RRAGD DBF4 FAM169A WDR12 MPHOSPH10 PHIP RBM34 ZNF292 | 6.33e-07 | 1241 | 114 | 22 | facebase_RNAseq_e10.5_MandArch_2500_K1 |
| CoexpressionAtlas | facebase_RNAseq_e10.5_MandArch_2500 | ASNSD1 CACNA1C EME1 SP100 PDE3B CENPC RRP1B ATAD5 CEP290 ZDBF2 CHD7 THOC2 DHX30 POSTN MDN1 RESF1 RRAGD DBF4 FAM169A WDR12 MPHOSPH10 PHIP RBM34 ZNF292 | 7.69e-07 | 1468 | 114 | 24 | facebase_RNAseq_e10.5_MandArch_2500 |
| CoexpressionAtlas | FacebaseRNAseq_e8.5_Hind Brain Neural Epithelium_top-relative-expression-ranked_1000_k-means-cluster#5 | 1.59e-06 | 204 | 114 | 9 | Facebase_RNAseq_e8.5_Hind Brain Neural Epithelium_1000_K5 | |
| CoexpressionAtlas | FacebaseRNAseq_e10.5_Neural Epithelium Overlying Lateral Eminence_top-relative-expression-ranked_2500_k-means-cluster#5 | EME1 PDE3B RNF168 ATAD5 FAT3 CEP290 MAMLD1 USP25 ZDBF2 CHD7 JADE1 DBF4 FAM169A MPHOSPH10 PHIP | 2.25e-06 | 654 | 114 | 15 | Facebase_RNAseq_e10.5_Neural Epithelium Overlying Lateral Eminence_2500_K5 |
| CoexpressionAtlas | facebase_RNAseq_e8.5_NeuroEpith_hindBrain_2500 | EME1 PDE3B MLEC RRP1B ATAD5 CEP290 ZDBF2 CHD7 BCAS1 JADE1 RFC1 POLR1G FGF18 LARP7 DHX15 MDN1 RRAGD DBF4 FAM169A CTHRC1 UHRF1 MPHOSPH10 | 2.46e-06 | 1347 | 114 | 22 | facebase_RNAseq_e8.5_NeuroEpith_hindBrain_2500 |
| CoexpressionAtlas | facebase_RNAseq_e10.5_Emin_LatNas_2500_K3 | BDP1 EME1 PDE3B RNF168 CENPC RRP1B ATAD5 CEP290 ZDBF2 RFC1 THOC2 LARP7 DHX30 MDN1 DBF4 PRIM2 FAM169A MPHOSPH10 CDC27 PHIP ZNF292 | 3.04e-06 | 1257 | 114 | 21 | facebase_RNAseq_e10.5_Emin_LatNas_2500_K3 |
| CoexpressionAtlas | FacebaseRNAseq_e10.5_Neural Epithelium Overlying Central Eminence_top-relative-expression-ranked_1000_k-means-cluster#4 | 4.79e-06 | 298 | 114 | 10 | Facebase_RNAseq_e10.5_Neural Epithelium Overlying Central Eminence_1000_K4 | |
| CoexpressionAtlas | FacebaseRNAseq_e8.5_Hind Brain Neural Epithelium_top-relative-expression-ranked_1000 | BDP1 EME1 ATAD5 USP25 ZDBF2 CHD7 JADE1 POLR1G NSUN2 FGF18 MDN1 CCDC71 RRAGD FAM169A CTHRC1 UHRF1 PPIE MPHOSPH10 | 5.47e-06 | 991 | 114 | 18 | Facebase_RNAseq_e8.5_Hind Brain Neural Epithelium_1000 |
| CoexpressionAtlas | FacebaseRNAseq_e10.5_Neural Epithelium Flanking Eminence_top-relative-expression-ranked_1000_k-means-cluster#2 | BDP1 EME1 RNF168 ATAD5 CEP290 CHD7 N4BP2L2 MPHOSPH10 PHIP ZNF292 | 6.98e-06 | 311 | 114 | 10 | Facebase_RNAseq_e10.5_Neural Epithelium Flanking Eminence_1000_K2 |
| CoexpressionAtlas | FacebaseRNAseq_e8.5_Floor Plate_top-relative-expression-ranked_2500_k-means-cluster#1 | BDP1 EME1 RNF168 CENPC ATAD5 CEP290 USP25 CHD7 FAM169A MPHOSPH10 PHIP ZNF292 | 8.44e-06 | 469 | 114 | 12 | Facebase_RNAseq_e8.5_Floor Plate_2500_K1 |
| CoexpressionAtlas | facebase_RNAseq_e10.5_Emin_LatNas_2500 | BDP1 EME1 PDE3B RNF168 CENPC RRP1B ATAD5 CEP290 ZDBF2 CHD7 RFC1 THOC2 LARP7 DHX30 MDN1 DBF4 PRIM2 FAM169A MPHOSPH10 CDC27 PHIP ZNF292 | 8.86e-06 | 1459 | 114 | 22 | facebase_RNAseq_e10.5_Emin_LatNas_2500 |
| CoexpressionAtlas | facebase_RNAseq_e10.5_MaxArch_2500_K3 | RAB23 EME1 PDE3B CENPC RRP1B ATAD5 CEP290 MYO1B CHD7 BCAS1 RFC1 THOC2 DHX30 MDN1 RESF1 DBF4 FAM169A MPHOSPH10 CDC27 ZNF292 | 1.05e-05 | 1252 | 114 | 20 | facebase_RNAseq_e10.5_MaxArch_2500_K3 |
| CoexpressionAtlas | FacebaseRNAseq_e10.5_Neural Epithelium Overlying Lateral Eminence_top-relative-expression-ranked_1000_k-means-cluster#2 | RNF168 ATAD5 FAT3 MAMLD1 USP25 ZDBF2 CHD7 DBF4 MPHOSPH10 PHIP | 1.11e-05 | 328 | 114 | 10 | Facebase_RNAseq_e10.5_Neural Epithelium Overlying Lateral Eminence_1000_K2 |
| CoexpressionAtlas | facebase_RNAseq_e10.5_NeuroEpith_central_2500_K4 | DENND2A EME1 CENPC RRP1B ATAD5 FAT3 CEP290 MAMLD1 ZDBF2 CHD7 RFC1 FGF18 LARP7 DHX30 GSTCD FAM169A UHRF1 MPHOSPH10 PHIP REV1 | 3.84e-05 | 1370 | 114 | 20 | facebase_RNAseq_e10.5_NeuroEpith_central_2500_K4 |
| CoexpressionAtlas | facebase_RNAseq_e8.5_FloorPlate_2500_K3 | RAB23 EME1 MLEC RRP1B ATAD5 FAT3 ZDBF2 JADE1 RFC1 POLR1G LARP7 DHX15 MDN1 RRAGD DBF4 FAM169A UHRF1 MPHOSPH10 CDC27 PHIP | 3.88e-05 | 1371 | 114 | 20 | facebase_RNAseq_e8.5_FloorPlate_2500_K3 |
| CoexpressionAtlas | alpha beta T cells, T.8Nve.PP, TCR+ CD8+ CD44low CD62Lhigh, Peyer's Patch, avg-1 | 5.40e-05 | 317 | 114 | 9 | GSM538412_500 | |
| CoexpressionAtlas | FacebaseRNAseq_e8.5_Hind Brain Neural Epithelium_top-relative-expression-ranked_500_k-means-cluster#4 | 5.60e-05 | 124 | 114 | 6 | Facebase_RNAseq_e8.5_Hind Brain Neural Epithelium_500_K4 | |
| CoexpressionAtlas | alpha beta T cells, T.8Nve.PP, TCRb+ CD8+ CD44low CD62L high, Peyer's Patch, avg-1 | 8.44e-05 | 336 | 114 | 9 | GSM538413_500 | |
| CoexpressionAtlas | dev gonad_e13.5_M_GermCell_Oct_top-relative-expression-ranked_1000 | ERCC6 FN1 RRP1B HORMAD1 ZC3H6 TASOR2 MDN1 DBF4 CHEK2 FAM169A CTHRC1 WDR12 MPHOSPH10 REV1 | 1.13e-04 | 810 | 114 | 14 | gudmap_dev gonad_e13.5_M_GermCell_Oct_1000 |
| CoexpressionAtlas | FacebaseRNAseq_e9.5_Mandibular Arch_top-relative-expression-ranked_1000_k-means-cluster#4 | 1.14e-04 | 203 | 114 | 7 | Facebase_RNAseq_e9.5_Mandibular Arch_1000_K4 | |
| CoexpressionAtlas | dev gonad_e13.5_F_MeioticGermCell_Oct_top-relative-expression-ranked_1000 | PDE3B ERCC6 MAGI3 PHF8 HORMAD1 ZC3H6 TASOR2 MDN1 DBF4 PRIM2 CHEK2 FAM169A NPAT REV1 | 1.28e-04 | 820 | 114 | 14 | gudmap_dev gonad_e13.5_F_MeioticGermCell_Oct_1000 |
| CoexpressionAtlas | dev gonad_e11.5_M_GonadVasMes_Flk_k-means-cluster#4_top-relative-expression-ranked_500 | 1.29e-04 | 207 | 114 | 7 | gudmap_dev gonad_e11.5_M_GonadVasMes_Flk_k4_500 | |
| CoexpressionAtlas | FacebaseRNAseq_e10.5_Neural Epithelium Flanking Eminence_top-relative-expression-ranked_2500_k-means-cluster#5 | BDP1 EME1 RNF168 ATAD5 FAT3 CEP290 MAMLD1 ZDBF2 CHD7 DBF4 N4BP2L2 MPHOSPH10 PHIP ZNF292 | 1.47e-04 | 831 | 114 | 14 | Facebase_RNAseq_e10.5_Neural Epithelium Flanking Eminence_2500_K5 |
| CoexpressionAtlas | dev gonad_e12.5_M_InterstitLeydig_MafB_top-relative-expression-ranked_500 | 1.54e-04 | 364 | 114 | 9 | gudmap_dev gonad_e12.5_M_InterstitLeydig_MafB_500 | |
| CoexpressionAtlas | DevelopingLowerUrinaryTract_e14.5_ urethra_emap-30902_k-means-cluster#3_top-relative-expression-ranked_1000 | 1.71e-04 | 369 | 114 | 9 | DevelopingLowerUrinaryTract_e14.5_ urethra_emap-30902_k3_1000 | |
| CoexpressionAtlas | dev gonad_e11.5_M_GonMes_Sma_top-relative-expression-ranked_1000 | DENND2A ERCC6 FN1 RRP1B ZDBF2 CHD7 FGF18 ADAMTS12 POSTN RESF1 HMCN1 PCDH11X FAM169A UHRF1 | 1.84e-04 | 849 | 114 | 14 | gudmap_dev gonad_e11.5_M_GonMes_Sma_1000 |
| CoexpressionAtlas | facebase_RNAseq_e9.5_OlfPlac_2500_K3 | DTD1 RAB23 EME1 PDE3B USP25 TFIP11 ZDBF2 CHD7 RFC1 NSUN2 MDN1 RRAGD DBF4 MTFR1 GSTCD FAM169A UHRF1 | 1.97e-04 | 1187 | 114 | 17 | facebase_RNAseq_e9.5_OlfPlac_2500_K3 |
| CoexpressionAtlas | CD positive, CD4 Control, 4+8-B220-, Spleen, avg-2 | 2.09e-04 | 224 | 114 | 7 | GSM403994_500 | |
| CoexpressionAtlas | FacebaseRNAseq_e10.5_Neural Epithelium Overlying Central Eminence_top-relative-expression-ranked_1000 | EME1 SP100 ERCC6 CENPC ATAD5 FAT3 CEP290 MAMLD1 ZDBF2 CHD7 FGF18 GSTCD PCDH11X PHIP ZNF292 | 2.56e-04 | 986 | 114 | 15 | Facebase_RNAseq_e10.5_Neural Epithelium Overlying Central Eminence_1000 |
| CoexpressionAtlas | FacebaseRNAseq_e10.5_Maxillary Arch_top-relative-expression-ranked_1000 | BDP1 SP100 WIPI1 STARD8 ERCC6 RNF168 ATAD5 CEP290 MAMLD1 CHD7 DHX30 PCDH11X FAM169A PHIP ZNF292 | 2.64e-04 | 989 | 114 | 15 | Facebase_RNAseq_e10.5_Maxillary Arch_1000 |
| CoexpressionAtlas | dev gonad_e12.5_M_InterstitLeydig_MafB_k-means-cluster#2_top-relative-expression-ranked_500 | 2.68e-04 | 165 | 114 | 6 | gudmap_dev gonad_e12.5_M_InterstitLeydig_MafB_k2_500 | |
| CoexpressionAtlas | kidney_e10.5_UretericTrunk_HoxB7_k-means-cluster#2_top-relative-expression-ranked_100 | 2.83e-04 | 5 | 114 | 2 | gudmap_kidney_e10.5_UretericTrunk_HoxB7_k2_100 | |
| CoexpressionAtlas | FacebaseRNAseq_e9.5_Mandibular Arch_top-relative-expression-ranked_500 | 2.83e-04 | 484 | 114 | 10 | Facebase_RNAseq_e9.5_Mandibular Arch_500 | |
| CoexpressionAtlas | FacebaseRNAseq_e8.5_Hind Brain Neural Epithelium_top-relative-expression-ranked_500 | 3.44e-04 | 496 | 114 | 10 | Facebase_RNAseq_e8.5_Hind Brain Neural Epithelium_500 | |
| CoexpressionAtlas | alpha beta T cells, T.4Nve.PP, TCR+ CD4+ CD44low CD62Lhigh, Peyer's Patch, avg-2 | 3.88e-04 | 327 | 114 | 8 | GSM538380_500 | |
| CoexpressionAtlas | alpha beta T cells, T.4.Pa.BDC, 4+ 8- BDC+, Pancreas, avg-2 | 3.96e-04 | 328 | 114 | 8 | GSM605756_500 | |
| CoexpressionAtlas | dev gonad_e11.5_M_GonadVasMes_Flk_k-means-cluster#1_top-relative-expression-ranked_1000 | 4.74e-04 | 337 | 114 | 8 | gudmap_dev gonad_e11.5_M_GonadVasMes_Flk_k1_1000 | |
| CoexpressionAtlas | FacebaseRNAseq_e10.5_Mandibular Arch_top-relative-expression-ranked_500_k-means-cluster#5 | 5.08e-04 | 186 | 114 | 6 | Facebase_RNAseq_e10.5_Mandibular Arch_500_K5 | |
| CoexpressionAtlas | facebase_RNAseq_e10.5_Emin_MedNas_2500 | RAB23 EME1 SP100 PDE3B CENPC ATAD5 FAT3 CEP290 MAMLD1 ZDBF2 CHD7 BCAS1 DHX30 RRAGD DBF4 FAM169A MPHOSPH10 ZNF292 | 5.26e-04 | 1414 | 114 | 18 | facebase_RNAseq_e10.5_Emin_MedNas_2500 |
| CoexpressionAtlas | facebase_RNAseq_e10.5_Emin_MedNas_2500_K1 | RAB23 EME1 PDE3B CENPC ATAD5 FAT3 CEP290 MAMLD1 ZDBF2 CHD7 DHX30 DBF4 FAM169A MPHOSPH10 ZNF292 | 5.47e-04 | 1060 | 114 | 15 | facebase_RNAseq_e10.5_Emin_MedNas_2500_K1 |
| CoexpressionAtlas | FacebaseRNAseq_e10.5_Maxillary Arch_top-relative-expression-ranked_2500_k-means-cluster#5 | BDP1 PDS5B RNF168 ATAD5 CEP290 MAMLD1 CHD7 ZC3H11A FAM169A PHIP ZNF292 | 5.75e-04 | 629 | 114 | 11 | Facebase_RNAseq_e10.5_Maxillary Arch_2500_K5 |
| CoexpressionAtlas | FacebaseRNAseq_e10.5_Lateral Nasal Eminence_top-relative-expression-ranked_500_k-means-cluster#4 | 6.00e-04 | 192 | 114 | 6 | Facebase_RNAseq_e10.5_Lateral Nasal Eminence_500_K4 | |
| CoexpressionAtlas | kidney_P0_CapMes_Crym_k-means-cluster#3_top-relative-expression-ranked_1000 | 6.79e-04 | 74 | 114 | 4 | gudmap_kidney_P0_CapMes_Crym_k3_1000 | |
| CoexpressionAtlas | CD positive, T.8Nve.Sp.OT1, CD8+ CD45.1+, Spleen, avg-3 | 7.04e-04 | 358 | 114 | 8 | GSM605909_500 | |
| CoexpressionAtlas | FacebaseRNAseq_e10.5_Mandibular Arch_top-relative-expression-ranked_1000 | BDP1 CACNA1C EME1 CEP290 MAMLD1 ZDBF2 CHD7 RFC1 THOC2 DHX30 POSTN ZFR2 PCDH11X ATP2B4 | 7.57e-04 | 978 | 114 | 14 | Facebase_RNAseq_e10.5_Mandibular Arch_1000 |
| CoexpressionAtlas | CD positive, CD4 Test CJ, 4+8-B220-, Spleen, avg-2 | 7.97e-04 | 280 | 114 | 7 | GSM404003_500 | |
| CoexpressionAtlas | kidney_e10.5_UretericTip_HoxB7_k-means-cluster#3_top-relative-expression-ranked_500 | 8.41e-04 | 136 | 114 | 5 | gudmap_kidney_e10.5_UretericTip_HoxB7_k3_500 | |
| CoexpressionAtlas | FacebaseRNAseq_e10.5_Maxillary Arch_top-relative-expression-ranked_500_k-means-cluster#2 | 8.68e-04 | 79 | 114 | 4 | Facebase_RNAseq_e10.5_Maxillary Arch_500_K2 | |
| CoexpressionAtlas | kidney_P3_CapMes_Crym_top-relative-expression-ranked_500 | 8.72e-04 | 370 | 114 | 8 | gudmap_kidney_P3_CapMes_Crym_500 | |
| CoexpressionAtlas | kidney_e10.5_UretericTrunk_HoxB7_top-relative-expression-ranked_100 | 9.54e-04 | 81 | 114 | 4 | gudmap_kidney_e10.5_UretericTrunk_HoxB7_100 | |
| CoexpressionAtlas | FacebaseRNAseq_e10.5_Lateral Nasal Eminence_top-relative-expression-ranked_1000_k-means-cluster#3 | 9.97e-04 | 291 | 114 | 7 | Facebase_RNAseq_e10.5_Lateral Nasal Eminence_1000_K3 | |
| CoexpressionAtlas | facebase_RNAseq_e9.5_MaxArch_2500 | EME1 PDE3B RRP1B CHD7 POLR1G FZD4 POSTN MDN1 RRAGD HMCN1 DBF4 MTFR1 PRIM2 FAM169A CTHRC1 UHRF1 WDR12 | 1.02e-03 | 1371 | 114 | 17 | facebase_RNAseq_e9.5_MaxArch_2500 |
| CoexpressionAtlas | kidney_P2_CapMes_Crym_k-means-cluster#4_top-relative-expression-ranked_1000 | 1.04e-03 | 83 | 114 | 4 | gudmap_kidney_P2_CapMes_Crym_k4_1000 | |
| CoexpressionAtlas | kidney_e10.5_UretericTip_HoxB7_top-relative-expression-ranked_1000 | EME1 PDE3B ATAD5 FAT3 MAGI3 CHD7 FZD4 HMCN1 DBF4 CHEK2 FAM169A CTHRC1 | 1.07e-03 | 787 | 114 | 12 | gudmap_kidney_e10.5_UretericTip_HoxB7_1000 |
| CoexpressionAtlas | kidney_e10.5_UretericTip_HoxB7_top-relative-expression-ranked_500 | 1.11e-03 | 384 | 114 | 8 | gudmap_kidney_e10.5_UretericTip_HoxB7_500 | |
| CoexpressionAtlas | PP_GMP_top-relative-expression-ranked_2500_k-means-cluster#1 | 1.17e-03 | 299 | 114 | 7 | PP_GMP_2500_K1 | |
| CoexpressionAtlas | dev gonad_e12.5_M_GermCellTestis_Oct_top-relative-expression-ranked_1000 | RRP1B JADE1 HORMAD1 HELB MDN1 DBF4 CHEK2 FAM169A CTHRC1 WDR12 MPHOSPH10 REV1 | 1.17e-03 | 795 | 114 | 12 | gudmap_dev gonad_e12.5_M_GermCellTestis_Oct_1000 |
| CoexpressionAtlas | kidney_P1_CapMes_Crym_k-means-cluster#2_top-relative-expression-ranked_100 | 1.25e-03 | 10 | 114 | 2 | gudmap_kidney_P1_CapMes_Crym_k2_100 | |
| CoexpressionAtlas | DevelopingLowerUrinaryTract_e14.5_ urethra_emap-30892_k-means-cluster#5_top-relative-expression-ranked_500 | 1.26e-03 | 149 | 114 | 5 | gudmap_developingLowerUrinaryTract_e14.5_ urethra_500_k5 | |
| CoexpressionAtlas | alpha beta T cells, T.DPbl.Th, 4+ 8+ TCR-/lo FSChi, Thymus, avg-3 | 1.39e-03 | 398 | 114 | 8 | GSM399397_500 | |
| CoexpressionAtlas | DevelopingGonad_e11.5_ovary + mesonephros_emap-3226_top-relative-expression-ranked_1000 | CEP290 USP25 CHD7 THOC2 FZD4 ZC3H11A RESF1 RRAGD MTFR1 PCDH11X PCMTD2 BZW1 | 1.44e-03 | 815 | 114 | 12 | gudmap_developingGonad_e11.5_ovary + mesonephros_1000 |
| CoexpressionAtlas | facebase_RNAseq_e8.5_ParaxMesoderm_2500_K2 | EME1 PDE3B RRP1B POLG CHD7 BCAS1 POLR1G TASOR2 MDN1 RRAGD DBF4 FAM169A CTHRC1 UHRF1 MPHOSPH10 | 1.55e-03 | 1175 | 114 | 15 | facebase_RNAseq_e8.5_ParaxMesoderm_2500_K2 |
| CoexpressionAtlas | dev gonad_e11.5_M_GonadVasMes_Flk_top-relative-expression-ranked_1000 | DENND2A FAT3 ZDBF2 CHD7 PHF8 ADAMTS12 POSTN HMCN1 PTPRG PCDH11X UHRF1 ATP2B4 | 1.63e-03 | 827 | 114 | 12 | gudmap_dev gonad_e11.5_M_GonadVasMes_Flk_1000 |
| ToppCell | (03)_KRT6B+-(2)_GFP_FOXI1|(03)_KRT6B+ / shred by cell type by condition | SP100 CEP290 USP25 BCAS1 JADE1 RFC1 LARP7 ZC3H11A FOXP1 ZNF292 | 1.35e-10 | 199 | 117 | 10 | c425e7975f492ed5cfcca022248adb627e1d27d4 |
| ToppCell | mild|World / Cohort 1 (10x PBMC) with disease condition, cell group and cell class | BDP1 SP100 CENPC TRIP12 IFIT1 RESF1 KMT2A N4BP2L2 PHIP ZNF292 | 1.42e-10 | 200 | 117 | 10 | 12f1685ce8f218433068e090c9d839cd5a1910bf |
| ToppCell | PND03-Endothelial-Endothelial_blood-vessel-Macrovascular_EC-VEC-VEC_prolif|PND03 / Age_group by Lineage, Lineage_subclass, Cell_type, subtypes-by-prolif | 1.11e-08 | 161 | 117 | 8 | f4f5d6eaa32169de699c8ff8e8ae35179c8e25c0 | |
| ToppCell | Fetal_29-31_weeks-Mesenchymal-matrix_fibroblast_1_cell|Fetal_29-31_weeks / Lineage, Cell type, age group and donor | 4.72e-08 | 194 | 117 | 8 | 011e14d9ed1393275f892060e7708ffadcd0767f | |
| ToppCell | H1299-infected-SARSCoV2|infected / Cell line, Condition and Strain | 5.31e-08 | 197 | 117 | 8 | 0fa3e4cf93e77d78b1f97b906c5b13ca741ae17e | |
| ToppCell | metastatic_Brain-Fibroblasts-Myofibroblasts|metastatic_Brain / Location, Cell class and cell subclass | 5.19e-07 | 181 | 117 | 7 | bd0b5f74f9c81ec0f1592710774a4fdf33d9d5a9 | |
| ToppCell | Control-Fibroblasts-Alveolar_FB|Control / group, cell type (main and fine annotations) | 6.46e-07 | 187 | 117 | 7 | 92d468dde81125d51daf7abd4703741abe1ab91c | |
| ToppCell | Control-Fibroblasts-Other_FB|Control / group, cell type (main and fine annotations) | 6.46e-07 | 187 | 117 | 7 | bd3739c4a52aa1ba5deffd778e113a9800f7e158 | |
| ToppCell | -Unknown-Endothelial-Myofibroblast| / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2 | 6.69e-07 | 188 | 117 | 7 | 6468fa95ad0395395301115286f2d8c0df5d3882 | |
| ToppCell | -Unknown-Endothelial| / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2 | 6.69e-07 | 188 | 117 | 7 | 7a81ac5c79c3eb26639b52d2b9fd5e7ef9798fd6 | |
| ToppCell | -Unknown| / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2 | 6.69e-07 | 188 | 117 | 7 | 9cb718bfe1358c6fd842f096e228eb0abb9aefc6 | |
| ToppCell | Control-Fibroblasts|Control / group, cell type (main and fine annotations) | 7.19e-07 | 190 | 117 | 7 | 3a42a9b98d954685d38a741f44545898d0e3e9ce | |
| ToppCell | 10x5'-lymph-node_spleen-Lymphocytic_T_CD4-T_CD4/CD8|lymph-node_spleen / Manually curated celltypes from each tissue | 7.71e-07 | 192 | 117 | 7 | 47646d7e4990be85072987f92bf18d52f8da752e | |
| ToppCell | Children_(3_yrs)-Mesenchymal-matrix_fibroblast_1_cell|Children_(3_yrs) / Lineage, Cell type, age group and donor | 7.98e-07 | 193 | 117 | 7 | 99525545552b371c86b18b6ea6f4897dc6e9a9ec | |
| ToppCell | Children_(3_yrs)-Mesenchymal-matrix_fibroblast_1_cell-D032|Children_(3_yrs) / Lineage, Cell type, age group and donor | 7.98e-07 | 193 | 117 | 7 | b3ad5ff480d99217f36cc7471e5a96a519ddb409 | |
| ToppCell | Mesenchymal-matrix_fibroblast_1_cell|World / Lineage, Cell type, age group and donor | 7.98e-07 | 193 | 117 | 7 | acad568621ed677031797b8c2e34dafea798d681 | |
| ToppCell | Control-Fibroblasts-Intermediate_pathological_FB|Control / group, cell type (main and fine annotations) | 8.26e-07 | 194 | 117 | 7 | 03a269f75a481ea54aea8e6444605db8d6df493d | |
| ToppCell | COVID-19-Fibroblasts-Alveolar_FB|COVID-19 / group, cell type (main and fine annotations) | 8.55e-07 | 195 | 117 | 7 | 603050beeb33c331d4b2e3fa46cae3f3e0e4bdc7 | |
| ToppCell | Children_(3_yrs)-Mesenchymal|Children_(3_yrs) / Lineage, Cell type, age group and donor | 8.85e-07 | 196 | 117 | 7 | bc94909f9b2dc08a59eef1914148b69720569c8f | |
| ToppCell | COVID-19-Fibroblasts-Intermediate_pathological_FB|COVID-19 / group, cell type (main and fine annotations) | 9.16e-07 | 197 | 117 | 7 | f1c8936986123a3151140c374fcd62d6705c530b | |
| ToppCell | severe-low-quality_cells|World / Cohort 1 (10x PBMC) with disease condition, cell group and cell class | 9.16e-07 | 197 | 117 | 7 | 57ebd552f10d6278623b52a3d484d4b91ae1d028 | |
| ToppCell | IPF-Stromal-Myofibroblast|Stromal / Disease state, Lineage and Cell class | 9.16e-07 | 197 | 117 | 7 | f304d42fc4936fe20996e07c8dccc698a6e5e5ef | |
| ToppCell | Fetal_29-31_weeks-Mesenchymal|Fetal_29-31_weeks / Lineage, Cell type, age group and donor | 9.47e-07 | 198 | 117 | 7 | 21cf4d81386761d09d0f6829c01c198e5524176d | |
| ToppCell | mild-low-quality_cells|World / Cohort 1 (10x PBMC) with disease condition, cell group and cell class | 9.80e-07 | 199 | 117 | 7 | f0b0097df0026496470a80d8cc9375ffd8389b00 | |
| ToppCell | Mesenchymal|World / Lineage, Cell type, age group and donor | 9.80e-07 | 199 | 117 | 7 | 4bac110c2b3609f6ee5d0e3275da0824a6240270 | |
| ToppCell | (04)_Interm._basal>secr.-(2)_GFP_FOXI1|(04)_Interm._basal>secr. / shred by cell type by condition | 9.80e-07 | 199 | 117 | 7 | 53ca3861f9e00dab3f3fbefb0837857ee39ab084 | |
| ToppCell | (09)_Interm._secr.>cil.-(2)_GFP_FOXI1|(09)_Interm._secr.>cil. / shred by cell type by condition | 9.80e-07 | 199 | 117 | 7 | fc680f85ebd3bab4c72876a19a461b0afb5f51ce | |
| ToppCell | mild-CD4+_Tcm|World / Cohort 1 (10x PBMC) with disease condition, cell group and cell class | 9.80e-07 | 199 | 117 | 7 | 06c8a0e39f7a33736548f04a5e2263334c8541cf | |
| ToppCell | (01)_IL1RL1+-(2)_GFP_FOXI1|(01)_IL1RL1+ / shred by cell type by condition | 9.80e-07 | 199 | 117 | 7 | a2f7d0cabf35b80fe239fae34a77bf9344d5d743 | |
| ToppCell | LPS_IL1RA-Endothelial-Endothelial-Gen_Cap|LPS_IL1RA / Treatment groups by lineage, cell group, cell type | 1.01e-06 | 200 | 117 | 7 | dccec522ab0d7fff62ad6273b02aa9022dbbb8eb | |
| ToppCell | Bronchial-NucSeq-Stromal|NucSeq / Cell types per location group and 10X technology with lineage, and cell group designations | 1.01e-06 | 200 | 117 | 7 | 389cc775c8419d90fb77cd794376d2160a7bf44e | |
| ToppCell | saliva-Mild-Moderate_progression_d12-25-Myeloid-Granulocytic-Neutrophil-Neu_c4-RSAD2|Mild-Moderate_progression_d12-25 / Compartment, severity and other cell annotations on 10x 3' data (130k) | 3.59e-06 | 156 | 117 | 6 | f5889a6899904dfb7f596600b3a76857cf9d5378 | |
| ToppCell | PND07-Mesenchymal-Mesenchymal_myocytic-Myofibroblast_vascular-Pericyte-Pericyte_prolif|PND07 / Age_group by Lineage, Lineage_subclass, Cell_type, subtypes-by-prolif | 6.30e-06 | 172 | 117 | 6 | 03a0aff6b7971093a4347b5ed12546d78374c56f | |
| ToppCell | facs-Kidney-nan-24m-Mesenchymal-kidney_interstitial_fibroblast|Kidney / Skin_Bladder_Kidney_Mammary_Gland - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 8.43e-06 | 181 | 117 | 6 | c7f5aedcb74c21fb587a95a16d700e2a38a380ee | |
| ToppCell | facs-Kidney-nan-24m-Mesenchymal-kidney_interstitial_fibroblast|Kidney / Skin_Bladder_Kidney_Mammary_Gland - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 8.43e-06 | 181 | 117 | 6 | 0ec9621a078d004bbd25a587757d24b5cf162959 | |
| ToppCell | Fetal_29-31_weeks-Mesenchymal-myofibroblast_cell|Fetal_29-31_weeks / Lineage, Cell type, age group and donor | 1.01e-05 | 187 | 117 | 6 | c104fbfef2d0bef64077ac721edf2379fd59d547 | |
| ToppCell | Mesenchymal-myofibroblast_cell|World / Lineage, Cell type, age group and donor | 1.08e-05 | 189 | 117 | 6 | 44e37f88137bb249933eb615235b2cf2ae7f3925 | |
| ToppCell | Fetal_29-31_weeks-Mesenchymal-matrix_fibroblast_1_cell-D088|Fetal_29-31_weeks / Lineage, Cell type, age group and donor | 1.14e-05 | 191 | 117 | 6 | 08720998aa55131d7377c4c67c4c935865bd7d79 | |
| ToppCell | nucseq-Mesenchymal-Fibroblastic-Fibroblastic_2-AF1|nucseq / Celltype signatures by Technology, Lineage, Lineage_subclass, Celltype_group, Cell_type2 | 1.14e-05 | 191 | 117 | 6 | 6688cee34beee4f151ac17fccbc9c26a9aad72e1 | |
| ToppCell | IPF-Endothelial-VE_Arterial|Endothelial / Disease state, Lineage and Cell class | 1.18e-05 | 192 | 117 | 6 | e911e286da26202853f9650ba3cdefe5a5c9b585 | |
| ToppCell | nucseq-Mesenchymal-Myocytic-Myocytic_2-SCMF|nucseq / Celltype signatures by Technology, Lineage, Lineage_subclass, Celltype_group, Cell_type2 | 1.18e-05 | 192 | 117 | 6 | 67e845e513e76e820f55e2f0d15eb16f2944d05c | |
| ToppCell | COVID-19_Moderate-CD4+_T_activated|COVID-19_Moderate / disease group, cell group and cell class | 1.18e-05 | 192 | 117 | 6 | 7a81652406332afd03a9b3b529e9b5e6c0b54c28 | |
| ToppCell | nucseq-Mesenchymal-Fibroblastic-Fibroblastic_2|nucseq / Celltype signatures by Technology, Lineage, Lineage_subclass, Celltype_group, Cell_type2 | 1.18e-05 | 192 | 117 | 6 | 99ce9e3c4c50cf64ebb62145f2b5420efa0db309 | |
| ToppCell | COPD-Stromal-Myofibroblast|Stromal / Disease state, Lineage and Cell class | 1.18e-05 | 192 | 117 | 6 | 62904f94dfce430456f05066522cbf9bd29f4d7e | |
| ToppCell | COVID-19_Moderate-CD4+_T_activated|World / disease group, cell group and cell class | 1.21e-05 | 193 | 117 | 6 | c2a2a2c14a7085690262db5c2a70e38db67dee18 | |
| ToppCell | COVID-19-Fibroblasts-Other_FB|COVID-19 / group, cell type (main and fine annotations) | 1.21e-05 | 193 | 117 | 6 | e6b75be08e33c1de079fb5c02f0b4468128b369c | |
| ToppCell | Adult-Mesenchymal-matrix_fibroblast_1_cell-D231|Adult / Lineage, Cell type, age group and donor | 1.21e-05 | 193 | 117 | 6 | ef2f456c094e6e3c6ee81e0668c953cb8d0e1c0a | |
| ToppCell | Control-Stromal-Myofibroblast|Stromal / Disease state, Lineage and Cell class | 1.21e-05 | 193 | 117 | 6 | 5896242f713ae5fd1a4ebb63827f15d7279dced2 | |
| ToppCell | nucseq-Mesenchymal-Myocytic-Myocytic_2|nucseq / Celltype signatures by Technology, Lineage, Lineage_subclass, Celltype_group, Cell_type2 | 1.21e-05 | 193 | 117 | 6 | 5de87fc94a6e58899ef4124cf4887ed3ff96163a | |
| ToppCell | droplet-Limb_Muscle-MUSCLE|Limb_Muscle / Tongue_Heart_Limb_Muscle_Aorta_Diaphragm - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 1.25e-05 | 194 | 117 | 6 | e3d63874111d1e8da3977329426e4dcf68d6de87 | |
| ToppCell | Adult-Mesenchymal-matrix_fibroblast_1_cell|Adult / Lineage, Cell type, age group and donor | 1.29e-05 | 195 | 117 | 6 | 61c9e09fc84d1012e472185d70ad0a06cee30d6e | |
| ToppCell | PBMC_fresh-frozen-Mild-Moderate_progression_d12-25-Lymphocytic|Mild-Moderate_progression_d12-25 / Compartment, severity and other cell annotations on 10x 3' data (130k) | 1.29e-05 | 195 | 117 | 6 | ed5f772c82d4dfd1c8735224446ec9feae3fb8c2 | |
| ToppCell | Adult-Mesenchymal-matrix_fibroblast_1_cell-D122|Adult / Lineage, Cell type, age group and donor | 1.29e-05 | 195 | 117 | 6 | aa0add081881d349099d12efca5cdee098038d4e | |
| ToppCell | nucseq-Mesenchymal-Fibroblastic|nucseq / Celltype signatures by Technology, Lineage, Lineage_subclass, Celltype_group, Cell_type2 | 1.33e-05 | 196 | 117 | 6 | 7d8505dac15fa59935ccf592afc54b04c4c6554f | |
| ToppCell | PCW_13-14-Mesenchymal|PCW_13-14 / Celltypes from embryonic and fetal-stage human lung | 1.36e-05 | 197 | 117 | 6 | 73a2085d2682d636726a5432d572ae2a3fbe1c3f | |
| ToppCell | mild-Treg|World / Cohort 1 (10x PBMC) with disease condition, cell group and cell class | 1.36e-05 | 197 | 117 | 6 | 39800e6e83f2d333b753d121c7aeb2912b91faa2 | |
| ToppCell | COVID-19-Fibroblasts|COVID-19 / group, cell type (main and fine annotations) | 1.36e-05 | 197 | 117 | 6 | fb847f2277609c31fffcdf49517243ce0684facf | |
| ToppCell | COVID-19-lung-Fibroblast|lung / Disease (COVID-19 only), tissue and cell type | 1.40e-05 | 198 | 117 | 6 | df3de77216f5c5d6141ec44d01c56b942f611838 | |
| ToppCell | nucseq-Mesenchymal|nucseq / Celltype signatures by Technology, Lineage, Lineage_subclass, Celltype_group, Cell_type2 | 1.40e-05 | 198 | 117 | 6 | 8f52243ca8b9ba68a75ae411506a3a6de258eb97 | |
| ToppCell | Fetal_29-31_weeks|World / Lineage, Cell type, age group and donor | 1.44e-05 | 199 | 117 | 6 | 5b9d355795dd03a22f0961dfd143425c367a4654 | |
| ToppCell | (00)_Basal-(2)_GFP_FOXI1|(00)_Basal / shred by cell type by condition | 1.44e-05 | 199 | 117 | 6 | 19674e1eaeb51e4196d847cb62aa437c852951d3 | |
| ToppCell | mild-CD4+_T_naive|World / Cohort 1 (10x PBMC) with disease condition, cell group and cell class | 1.44e-05 | 199 | 117 | 6 | 3e4baaf4ee23f257d821194468102c00a8ad2f21 | |
| ToppCell | PCW_10-12-Mesenchymal|PCW_10-12 / Celltypes from embryonic and fetal-stage human lung | 1.44e-05 | 199 | 117 | 6 | a09292de4c4447b8eee55d401808e43b817321cc | |
| ToppCell | TCGA-Stomach-Primary_Tumor|TCGA-Stomach / Sample_Type by Project: Shred V9 | 1.44e-05 | 199 | 117 | 6 | 38f1f612b29feb868322999ceeda78e52447ec4f | |
| ToppCell | TCGA-Stomach-Primary_Tumor-Stomach_Adenocarcinoma|TCGA-Stomach / Sample_Type by Project: Shred V9 | 1.44e-05 | 199 | 117 | 6 | b10698aee2e6c17bc559eb4f723024141f914b90 | |
| ToppCell | Bronchial-NucSeq-Stromal-Fibroblastic-Fibro_alveolar|NucSeq / Cell types per location group and 10X technology with lineage, and cell group designations | 1.49e-05 | 200 | 117 | 6 | e8462395fee0a532d1e7ec7f1795f28c42af6541 | |
| ToppCell | Parenchymal-NucSeq-Stromal|NucSeq / Cell types per location group and 10X technology with lineage, and cell group designations | 1.49e-05 | 200 | 117 | 6 | cf433f9b43d7db07acaf70e060f8f77c974e72f3 | |
| ToppCell | Bronchial-NucSeq-Stromal-Fibroblastic|NucSeq / Cell types per location group and 10X technology with lineage, and cell group designations | 1.49e-05 | 200 | 117 | 6 | cae972324d1dfea6efeaf6013f265c7c6bb48db4 | |
| ToppCell | mild-CD8+_T_naive|World / Cohort 1 (10x PBMC) with disease condition, cell group and cell class | 1.49e-05 | 200 | 117 | 6 | c825320599a61a4c629d736f5c0fd6f1f405540a | |
| ToppCell | Parenchymal-NucSeq-Stromal-Fibroblastic|NucSeq / Cell types per location group and 10X technology with lineage, and cell group designations | 1.49e-05 | 200 | 117 | 6 | 311fab076f2ceb258e3970eb21e39344b894042a | |
| ToppCell | Parenchymal-NucSeq-Stromal-Fibroblastic-Fibro_alveolar|NucSeq / Cell types per location group and 10X technology with lineage, and cell group designations | 1.49e-05 | 200 | 117 | 6 | 34f52003988ce6329d8deeee1ab875fa77e01e9d | |
| ToppCell | LPS_anti-TNF-Endothelial-Endothelial-Artery|LPS_anti-TNF / Treatment groups by lineage, cell group, cell type | 1.49e-05 | 200 | 117 | 6 | b1ff8d61b567f85006d6d20093f9c803b6d34674 | |
| ToppCell | facs-Skin-Telogen-3m-Epithelial-inner_bulge|Skin / Skin_Bladder_Kidney_Mammary_Gland - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 5.76e-05 | 156 | 117 | 5 | ba9dfee9373d657d2a55572b41fc62001ad8b037 | |
| ToppCell | 10x5'-bone_marrow-Lymphocytic_T_CD4-T_CD4/CD8|bone_marrow / Manually curated celltypes from each tissue | 5.76e-05 | 156 | 117 | 5 | 1545169694f686d28648a68b552c2ae606599d66 | |
| ToppCell | PND14-Immune-Immune_Lymphocytic_T/NK-Lymphocytic_T-CD8_T-CD8_T_prolif|PND14 / Age_group by Lineage, Lineage_subclass, Cell_type, subtypes-by-prolif | 6.30e-05 | 159 | 117 | 5 | e9c51e611ebd427bbe51e3e036c14122c36ea372 | |
| ToppCell | frontal_cortex-Neuronal-glutamatergic_neuron-L5_IT-L5_IT_ALM_Pld5|frontal_cortex / Per Region, Lineage, Cell class, Cell type, Cell subtype | 6.30e-05 | 159 | 117 | 5 | a082e770fa757c4a1d3ed13d53f83297e36faf05 | |
| ToppCell | Adult-Mesenchymal-chondrocyte|Adult / Lineage, Cell type, age group and donor | 6.30e-05 | 159 | 117 | 5 | 3f7305ee76447064b5c846c4f576360a2f7e0b7c | |
| ToppCell | frontal_cortex-Neuronal-glutamatergic_neuron-L5_IT-L5_IT_ALM_Cbln4_Fezf2|frontal_cortex / Per Region, Lineage, Cell class, Cell type, Cell subtype | 6.49e-05 | 160 | 117 | 5 | d8241404d775f9a709abdf17988f36293fcf4c58 | |
| ToppCell | Adult-Mesenchymal-chondrocyte-D231|Adult / Lineage, Cell type, age group and donor | 7.30e-05 | 164 | 117 | 5 | 2ba57dce5f69a88f0d1e450b9780425e2d9ca7d4 | |
| ToppCell | droplet-Lung-21m-Hematologic-Lymphocytic_NK_ILC-natural_killer_cell-proliferating_NK|21m / method, tissue, age, lineage, sublineage, cell ontologies, cell type and subtype | 9.91e-05 | 175 | 117 | 5 | 6751ee4b312d7f87275f2c35e5878cfc3be3ebe3 | |
| ToppCell | E18.5-Mesenchymal-Mesenchymal_myocytic-Myofibroblast_vascular-Pericyte-Pericyte_G2M|E18.5 / Age_group by Lineage, Lineage_subclass, Cell_type, subtypes-by-prolif | 9.91e-05 | 175 | 117 | 5 | 3e56695a9db97cb1d3503425c48eb79bbf99213e | |
| ToppCell | renal_cortex_nuclei-CKD+DKD_normotensive-Mesenchymal-Myocytic_interstitial_cell-Myofibroblast-|CKD+DKD_normotensive / Celltypes from Cells and Nuclei per compartment and clinical group | 1.02e-04 | 176 | 117 | 5 | 9bc87cd5cda2372e1bce94c9dfd408eb1dfd8d0c | |
| ToppCell | renal_cortex_nuclei-CKD+DKD_normotensive-Mesenchymal-Myocytic_interstitial_cell-Myofibroblast|CKD+DKD_normotensive / Celltypes from Cells and Nuclei per compartment and clinical group | 1.02e-04 | 176 | 117 | 5 | 3f8274a7ab67f9f8a8923193763a5543cfe4defa | |
| ToppCell | 5'-Airway_Nasal-Mesenchymal-Fibroblastic|5' / 5'-vs-3', Tissue groups, Lineages, Lineage subclass, Cell_type2, Cell_subtype2_L4.5 | 1.13e-04 | 180 | 117 | 5 | 935c091bbcd6d10b81dc4731779e5bd98205c99f | |
| ToppCell | 5'-Airway_Nasal-Mesenchymal|5' / 5'-vs-3', Tissue groups, Lineages, Lineage subclass, Cell_type2, Cell_subtype2_L4.5 | 1.13e-04 | 180 | 117 | 5 | 3dd384b7f3d9582b8fec9fe05100e466e6218b76 | |
| ToppCell | renal_cortex_nuclei-Renal_AKI_(acute_kidney_injury)-Epithelial-Distal_tubule_epithelial_cell-kidney_distal_convoluted_tubule_epithelial_cell_cycling|Renal_AKI_(acute_kidney_injury) / Celltypes from Cells and Nuclei per compartment and clinical group | 1.13e-04 | 180 | 117 | 5 | 401df9cddcbca1eb8f0d2687bcacd98e95dc1493 | |
| ToppCell | Fetal_29-31_weeks-Mesenchymal-myofibroblast_cell-D062|Fetal_29-31_weeks / Lineage, Cell type, age group and donor | 1.16e-04 | 181 | 117 | 5 | d7e04e0ca549eac6d9b1192b6578f9b54943d54f | |
| ToppCell | Children_(3_yrs)-Mesenchymal-matrix_fibroblast_1_cell-D046|Children_(3_yrs) / Lineage, Cell type, age group and donor | 1.16e-04 | 181 | 117 | 5 | 9ede19228ba5c0668a9c06c915510b95585216ef | |
| ToppCell | COVID-19-Heart-EC_+_Pericyte|COVID-19 / Disease (COVID-19 only), tissue and cell type | 1.19e-04 | 182 | 117 | 5 | e67f3234165199085c793915ebb1f9bbd845e933 | |
| ToppCell | renal_cortex_nuclei-CKD+DKD_normotensive-Epithelial-Distal_tubule_epithelial_cell-kidney_loop_of_Henle_thick_ascending_limb_epithelial_cell|CKD+DKD_normotensive / Celltypes from Cells and Nuclei per compartment and clinical group | 1.19e-04 | 182 | 117 | 5 | a8cc56f32efe180e8fb5d69dbe606a794b3db700 | |
| ToppCell | Primary_Visual_cortex_(V1C)-Neuronal-Glutamatergic_Excit-Glut_E_(THEMIS)|Primary_Visual_cortex_(V1C) / Sample groups (6 Anatomical region groups), with 5 level hierarchy of cell types | 1.19e-04 | 182 | 117 | 5 | 205d9ad1ea4b7adee8054496cdde46c9c401a19a | |
| ToppCell | Calu_3-infected|Calu_3 / Cell line, Condition and Strain | 1.22e-04 | 183 | 117 | 5 | 8f7f5000645f24f20a8d7700c4df1f8953a1780b | |
| ToppCell | droplet-Lung-LUNG-1m-Lymphocytic-Proliferating_T|Lung / Lung_Trachea - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 1.22e-04 | 183 | 117 | 5 | 769a022fe8568ec49e66f792cc5777e713a7571c | |
| ToppCell | 5'-Airway_Nasal-Mesenchymal-Fibroblastic-fibroblastic_type_2|5' / 5'-vs-3', Tissue groups, Lineages, Lineage subclass, Cell_type2, Cell_subtype2_L4.5 | 1.22e-04 | 183 | 117 | 5 | 803376f5260de83c48d4f7301278d078a32b3e6e | |
| ToppCell | 5'-Airway_Nasal-Mesenchymal-Fibroblastic-fibroblastic_type_2-Peribronchial_fibroblasts-Peribronchial_fibroblasts_L.2.1.3.1|5' / 5'-vs-3', Tissue groups, Lineages, Lineage subclass, Cell_type2, Cell_subtype2_L4.5 | 1.22e-04 | 183 | 117 | 5 | 6d98973098c6d20c5305bce6a83a549a7d8dbfba | |
| ToppCell | 5'-Airway_Nasal-Mesenchymal-Fibroblastic-fibroblastic_type_2-Peribronchial_fibroblasts|5' / 5'-vs-3', Tissue groups, Lineages, Lineage subclass, Cell_type2, Cell_subtype2_L4.5 | 1.22e-04 | 183 | 117 | 5 | cc7f5a17b40e8d901885174922e5fa8877643071 | |
| ToppCell | droplet-Lung-LUNG-1m-Lymphocytic-T_cell|Lung / Lung_Trachea - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 1.22e-04 | 183 | 117 | 5 | aac0695fafa59cabd920ee18b1139d3e00d898e8 | |
| ToppCell | facs-Thymus-Thymus_Epithelium-18m-Lymphocytic-thymocyte|Thymus / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 1.25e-04 | 184 | 117 | 5 | 2cbed6462fea2622871bb7e49b0df3d984239281 | |
| ToppCell | facs-Thymus-Thymus_Epithelium-18m-Lymphocytic|Thymus / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 1.25e-04 | 184 | 117 | 5 | ea7a7e2bac46d4d2c31a5d576b38a032b5335062 | |
| ToppCell | facs-Thymus-Thymus_Epithelium-18m-Lymphocytic-proliferating_thymocyte;_DN_to_DP_transition,_dividing_(some_are_Cd8+/_Cd4+,_some_undergoing_VDJ_recombination)|Thymus / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 1.25e-04 | 184 | 117 | 5 | 2b19a8c5f823e00812908b23e66bb4e563278aff | |
| Computational | Genes upregulated in subsets of cells of a given type within various tumors | 1.90e-05 | 49 | 73 | 5 | GAVISH_3CA_METAPROGRAM_CD8_T_CELLS_CHROMATIN | |
| Disease | Exudative vitreoretinopathy 1 | 1.40e-05 | 2 | 111 | 2 | cv:C1851402 | |
| Disease | EXUDATIVE VITREORETINOPATHY 1 | 1.40e-05 | 2 | 111 | 2 | 133780 | |
| Disease | Neurodevelopmental Disorders | 2.75e-05 | 93 | 111 | 5 | C1535926 | |
| Disease | Retinopathy of Prematurity | 4.20e-05 | 3 | 111 | 2 | C0035344 | |
| Disease | Colorectal Carcinoma | STARD8 ERCC6 FN1 MYO1B FZD4 POSTN CHEK2 PCDH11X PHIP BOLL ZNF292 | 7.01e-05 | 702 | 111 | 11 | C0009402 |
| Disease | Exudative vitreoretinopathy 1 | 8.37e-05 | 4 | 111 | 2 | C1851402 | |
| Disease | tendinitis (biomarker_via_orthology) | 2.08e-04 | 6 | 111 | 2 | DOID:971 (biomarker_via_orthology) | |
| Disease | Autism Spectrum Disorders | 3.04e-04 | 85 | 111 | 4 | C1510586 | |
| Disease | Burkitt Lymphoma | 3.38e-04 | 36 | 111 | 3 | C0006413 | |
| Disease | myocardial infarction | 3.68e-04 | 350 | 111 | 7 | EFO_0000612 | |
| Disease | exudative vitreoretinopathy (implicated_via_orthology) | 3.87e-04 | 8 | 111 | 2 | DOID:0050535 (implicated_via_orthology) | |
| Disease | breast carcinoma | PDS5B ATAD5 MAGI3 BCAS1 TASOR2 ZC3H11A TTBK1 CHEK2 FOXP1 PCMTD2 PHIP SMG6 | 4.61e-04 | 1019 | 111 | 12 | EFO_0000305 |
| Disease | Prostatic Neoplasms | 5.43e-04 | 616 | 111 | 9 | C0033578 | |
| Disease | Malignant neoplasm of prostate | 5.43e-04 | 616 | 111 | 9 | C0376358 | |
| Disease | coronary artery disease | RAB23 PDS5B WIPI1 FN1 RRP1B MAGI3 ZC3H11A PRIM2 UHRF1 N4BP2L2 WDR12 MPHOSPH10 SMG6 | 5.57e-04 | 1194 | 111 | 13 | EFO_0001645 |
| Disease | fibroblast growth factor 23 measurement | 5.73e-04 | 43 | 111 | 3 | EFO_0009381 | |
| Disease | squamous cell carcinoma, esophageal carcinoma | 6.19e-04 | 10 | 111 | 2 | EFO_0000707, EFO_0002916 | |
| Disease | ankyrin-2 measurement | 6.19e-04 | 10 | 111 | 2 | EFO_0021874 | |
| Disease | Microphthalmos | 7.54e-04 | 11 | 111 | 2 | C0026010 | |
| Disease | Shortened QT interval | 7.54e-04 | 11 | 111 | 2 | C0151879 | |
| Disease | Barrett's esophagus (is_implicated_in) | 7.54e-04 | 11 | 111 | 2 | DOID:9206 (is_implicated_in) | |
| Disease | vital capacity | DENND2A FN1 ATAD5 CHD7 TRIP12 FGF18 LARP7 ZGPAT HMCN1 GSTCD UHRF1 FOXP1 SMG6 | 7.67e-04 | 1236 | 111 | 13 | EFO_0004312 |
| Disease | Renal dysplasia and retinal aplasia (disorder) | 9.03e-04 | 12 | 111 | 2 | C0403553 | |
| Disease | testosterone measurement | SCP2D1-AS1 STARD8 CHD7 BCAS1 POLR1G TTBK1 HMCN1 PTPRG CHEK2 LRP5 FOXP1 ATP2B4 PHIP | 1.02e-03 | 1275 | 111 | 13 | EFO_0004908 |
| Disease | Disorder of eye | 1.26e-03 | 212 | 111 | 5 | C0015397 | |
| Disease | bacteriemia | 1.84e-03 | 17 | 111 | 2 | EFO_0003033 | |
| Disease | Age-related macular degeneration | 2.06e-03 | 18 | 111 | 2 | cv:C0242383 | |
| Disease | squamous cell carcinoma | 2.08e-03 | 67 | 111 | 3 | EFO_0000707 | |
| Disease | aspartate aminotransferase measurement, serum alanine aminotransferase measurement, low density lipoprotein triglyceride measurement, body fat percentage, high density lipoprotein cholesterol measurement, sex hormone-binding globulin measurement | 2.59e-03 | 364 | 111 | 6 | EFO_0004612, EFO_0004696, EFO_0004735, EFO_0004736, EFO_0007800, EFO_0009946 | |
| Disease | fibrinogen measurement, coronary artery disease | 2.77e-03 | 154 | 111 | 4 | EFO_0001645, EFO_0004623 | |
| Disease | Precursor B-cell lymphoblastic leukemia | 2.81e-03 | 21 | 111 | 2 | C1292769 | |
| Disease | free androgen index | 2.96e-03 | 374 | 111 | 6 | EFO_0007005 | |
| Disease | Hepatitis | 3.08e-03 | 22 | 111 | 2 | HP_0012115 | |
| Disease | Immunologic Deficiency Syndromes | 3.37e-03 | 23 | 111 | 2 | C0021051 | |
| Disease | DNA methylation | 3.40e-03 | 656 | 111 | 8 | GO_0006306 | |
| Disease | Neoplasm of the genitourinary tract | 3.67e-03 | 24 | 111 | 2 | cv:C0042065 | |
| Disease | Anhedonia | 3.67e-03 | 24 | 111 | 2 | C0178417 | |
| Disease | body fat percentage, coronary artery disease | 3.67e-03 | 24 | 111 | 2 | EFO_0001645, EFO_0007800 | |
| Disease | Pseudoaphakia | 3.67e-03 | 24 | 111 | 2 | C0524524 | |
| Disease | Lens Opacities | 3.67e-03 | 24 | 111 | 2 | C1510497 | |
| Disease | congestive heart failure (is_marker_for) | 3.70e-03 | 82 | 111 | 3 | DOID:6000 (is_marker_for) |
| Peptide | Gene | Start | Entry |
|---|---|---|---|
| KGNPKGRQNERVVIQ | 1006 | P23470 | |
| IPGKNREGNTQKKET | 491 | Q96QE3 | |
| KQESKNPKQELRGRG | 391 | Q86US8 | |
| PNIRKTGQRQIVDKG | 1581 | A6H8Y1 | |
| RKGGNVGKSKRDQIV | 681 | O71037 | |
| RKGGNVGKSKRDQIV | 681 | Q902F8 | |
| SEIPKGKQKAQLRQR | 31 | Q96CG8 | |
| QQKPTLSGQRFKTRK | 6 | Q7L1Q6 | |
| KKPQSVGICVRQKGR | 46 | Q5T5F5 | |
| KAAQGIQKSPKGRAV | 1206 | Q8N7X0 | |
| KKLNIGPAIRKQQVG | 101 | Q8N9W6 | |
| TQIKQKSRPGNKGKF | 46 | Q14512 | |
| NTELVGKGKRRPLNN | 171 | O96017 | |
| GKGKRRPLNNNSEIA | 176 | O96017 | |
| PKKQNGAIGRKVVVS | 406 | O43143 | |
| RQGKVTRQGKFKPNS | 1031 | Q7L2E3 | |
| GGIQVKNEKNRPSLK | 16 | Q9UBU7 | |
| RGRKGKKVKAQSTQP | 1691 | Q9P2D1 | |
| QKRALQFQGKVGLPK | 336 | Q03468 | |
| QKPGGSDFLRKRLQK | 41 | P56211 | |
| GKKQGVPENRNKAKT | 301 | P23634 | |
| RVLKPNKGTISNGKN | 1001 | P58397 | |
| GGDVINLRPNKQRTK | 211 | Q9ULC3 | |
| RINVELSTKGQKKGP | 141 | Q96PK6 | |
| QKRKNSQPGVKVADR | 141 | P42696 | |
| KLVQEQKPKGSQRSR | 1236 | Q9NTI5 | |
| QPKKNVRVGRSKQAA | 1386 | Q9NTI5 | |
| EVNNRNGKKTKRPRV | 406 | Q96DM1 | |
| NKRQPKLQGKSAETR | 436 | Q08J23 | |
| SQKAQGLRNKPCIGK | 991 | Q14207 | |
| QKRALQFQGKVGLPK | 336 | P0DP91 | |
| RKNTQSFKRKPGQAD | 5091 | Q9NU22 | |
| RKKQLGQVEIGSSKP | 376 | Q5TCQ9 | |
| KCKNARGQVGLVPKN | 236 | O43639 | |
| KKQTNKNRVQSGPRT | 246 | Q14165 | |
| NQRGGRALFQDIKKP | 71 | P02792 | |
| EDGRNKLKKQGETPN | 441 | Q17RB8 | |
| KPENFLIGRQGNKKE | 166 | Q9HCP0 | |
| GRQNIKRAKDDGTQP | 996 | O75197 | |
| KNGNGLKNTPRFKRR | 266 | Q9NV79 | |
| PAEKGDRKLNKGLNR | 416 | Q13370 | |
| KGRPRKGPKTRENQQ | 156 | O76093 | |
| QQVSGLKSPKRNDKQ | 76 | Q9H334 | |
| TKQGQKSQRKARRGP | 326 | P54098 | |
| VQNKGQGKPREKSIV | 186 | O00566 | |
| QAKLNQPREKKRGTE | 541 | Q4G0J3 | |
| QPQRKSEGKVAGKSQ | 1036 | Q9BZA7 | |
| RKGGNVGKSKRDQIV | 1441 | P63135 | |
| GKGIQKRSRLCNQPL | 4546 | Q96RW7 | |
| TRILKGQKNGKLGPE | 71 | P09923 | |
| EKRANAGKTLVKNNP | 216 | Q15390 | |
| SQRILNGGKDIKKEP | 451 | P49643 | |
| LVNSGKVKREKRGNG | 511 | Q9ULV1 | |
| KGFPKNITNNRGKKR | 341 | Q9NR20 | |
| QQQRKEKTRAKGPSE | 166 | Q8TEA8 | |
| RKGQKNRPETVGQKR | 376 | Q8IV32 | |
| KRKNILGAPGNKRIV | 2146 | Q9C0G6 | |
| KRKEQGLVGKPSQRN | 1681 | Q13936 | |
| VSGQRKKGPKSNLLA | 21 | Q2UY09 | |
| FNLGDPQNGRKKRKI | 466 | Q9ULE3 | |
| RKGGNVGKSKRDQIV | 681 | Q69384 | |
| IPLKRQKTATKGNQR | 576 | Q03188 | |
| KRQIKRLTSGLQGKP | 1851 | O15078 | |
| ALKNNQKSEPLIGRK | 2066 | P02751 | |
| RSGNEQGKFKINPKT | 3276 | Q8TDW7 | |
| RAGKGQKPRGKEQLA | 336 | P11229 | |
| TKGKRLPRALQQNGA | 256 | Q9BW60 | |
| GNLKRPKIGKRFQDS | 331 | Q9Y6X4 | |
| GNRQEPRKLQESGKK | 21 | Q13495 | |
| QIKEATKGQPRGQNR | 301 | P09914 | |
| TKGQPRGQNREKLDK | 306 | P09914 | |
| NLKQRGPNSSKQLLK | 26 | Q9NWL6 | |
| PKRNGKENGTENLKI | 2741 | Q03164 | |
| RKGGNVGKSKRDQIV | 681 | Q902F9 | |
| PRRGKQGANKQTKKQ | 376 | Q96AY2 | |
| NGNQPVKSSKENRKR | 346 | Q86X24 | |
| LQNGDKLQKRPEKRQ | 536 | O75363 | |
| KLQKRPEKRQQSLGG | 541 | O75363 | |
| RQIEAQGSKDGKPKQ | 276 | Q9UNP9 | |
| QNRLQKKKRATPNGT | 381 | Q9NQL2 | |
| GNRKEKGVAQRQVPT | 116 | Q9BR46 | |
| KQVQNKPKTGRSLLG | 256 | P30260 | |
| RRQKLKQQKADGVGP | 196 | Q8NEC7 | |
| GSPEDGSLKKKQRRQ | 51 | O75364 | |
| KETGRKDQKQPTQNG | 171 | Q8NG08 | |
| QGRGKDQPGRLKKVQ | 206 | O95954 | |
| KRRQVEQGPSTGAKK | 36 | E9PI22 | |
| NKRKEAEQQKGRRSP | 601 | Q9Y283 | |
| EPAIQVRRKGKGKQI | 736 | Q9NQT8 | |
| QRRRLQKKKAGPGSL | 566 | Q14684 | |
| KKKGEQPTGQQRRKH | 441 | Q92733 | |
| NGIKGLQRKERLKPA | 11 | O76011 | |
| SKLERTPQKNVQGKR | 501 | P35251 | |
| NILRNVKEKVGGKQP | 1531 | Q9HCM1 | |
| GEEAPTGRDKKRKQQ | 491 | O15446 | |
| FRIPKKGERQQQGEA | 751 | Q6IE81 | |
| KRRQVEQGPSTGAKK | 36 | P0DMB1 | |
| QGQEGPQDKAKKRHR | 111 | Q92502 | |
| NISEKINKRSGPKRG | 146 | Q16384 | |
| GSKKGPRGKLQAQRA | 1291 | Q5TCY1 | |
| KRKERGGRTNKGPNV | 226 | P61129 | |
| RKKEAAQKTGVQPNG | 296 | Q9UPR6 | |
| LTKENVKPSGRQIGK | 556 | Q8NI27 | |
| GRSPIVGNKRNQKLQ | 1256 | Q8N2C7 | |
| KRGPGRKPKVEVNTN | 1636 | Q8WWQ0 | |
| QRQSNGIFPGREKLK | 376 | Q9UBZ9 | |
| QKRGELQTKLKTEGP | 371 | O75152 | |
| SKVNGLQRGRKKDRP | 541 | P23497 | |
| QQSAPEKVKKDRGRG | 1336 | O60281 | |
| RKRQDKAPVGLKNVG | 161 | Q9UHP3 | |
| PQLTVKGRNLKGRQV | 596 | Q9HCK1 | |
| RRQAEKPKKGRVGSN | 6 | O75360 | |
| VLNGQRKNPKDGNFK | 486 | Q8IYW5 | |
| KPVRVVRNVKGGKNS | 531 | Q96T88 | |
| ELVKNIRGKVKGLQP | 66 | Q9NPG3 | |
| QGKRPKKGLATAKQR | 1031 | Q9UPP1 | |
| VKGQFPQKRKRGAEV | 391 | Q5VWN6 | |
| TNRPRKKQKTEQLGL | 231 | Q9GZL7 | |
| PIILCRGNQKGKTKQ | 431 | Q5MNZ9 | |
| DTPVRKLQANKKVQG | 811 | Q15063 | |
| ERQKTGQVPKKDNSR | 56 | Q14669 | |
| GQVPKKDNSRGVKRS | 61 | Q14669 | |
| NKELGTGLSQKRKAP | 1496 | Q92547 | |
| IKPSKGQRRGQAGVK | 1076 | Q6ZQQ6 | |
| GQRRGQAGVKKHSQK | 1081 | Q6ZQQ6 | |
| LQKQTRVGKAGTNKP | 381 | Q8N5A5 | |
| INPIEAKQRKGKGAV | 176 | Q9UBB9 | |
| KNGSVPTCKRKNNRL | 1116 | O43795 | |
| LNGINDRGGQKEKQK | 146 | Q92802 |